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Abstract  
 
Aims: The aim of the present study was to investigate 24 h interstitial glycaemia responses 
to interrupting prolonged sitting in free-living conditions in inactive and sedentary overweight 
and obese adults.  
Methods: Twelve overweight and obese individuals (mean ± SD age 47.5 ± 9.9 y) 
completed two, four-day conditions in a randomised crossover design; Uninterrupted sitting 
(SIT): 10 h/day sitting, 7 h/day uninterrupted bouts sitting (7 x 60 min bouts), standing and 
walking restricted to 1.5 h/day, or interrupting sitting (INT SIT): 3 – 6 min of standing, 
walking, simple body-weight resistance; half squats, lunges, calf raises, knee lifts, and 
repeated sit-to-stand transitions every 30 min for 10 h/day. Incremental area under the curve 
(iAUC) was calculated using the trapezoid method. 
Results: There were no significant differences observed for iAUC glucose measures 
between SIT and INT SIT conditions. There was no difference in sedentary behaviour 
between conditions, but daily stepping time and total steps increased significantly in INT SIT 
compared with SIT.  
Conclusion: In overweight and obese participants, it may not be possible to manipulate 
increases or decreases in sedentary behaviourin free-living conditions. Therefore, it was not 
possible to compare effects of interrupted sitting versus uninterrupted sitting on glycaemia.  
Key words: 
Sedentary behaviour; Interrupting pro-longed sitting; Obese adults; Glycaemia; Free-living 
conditions 
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1. Introduction  
Sedentary behaviours, such as prolonged sitting, have been associated with adverse 
metabolic health markers, including abnormal glycaemia (Dunstan et al., 2004), obesity 
(Healy et al., 2008), and insulin resistance (Helmerhorst et al., 2009). High levels of 
sedentary behaviour is a risk factor for insulin resistance, metabolic syndrome, and type 2 
diabetes (T2D), independent of light and moderate-physical activity (Venables and 
Jeukendrup, 2009; Edwardson et al., 2012; Proper et al., 2011; Van Uffelen et al., 2010). 
However, high levels of moderate-intensity physical activity (60 – 75 minutes per day) may 
protect against the increased mortality risk associated with high levels of sitting (Ekelund et 
al., 2016). Sedentary behaviour is any waking behaviour characterized by an energy 
expenditure ≤ 1.5 metabolic equivalents (METs), while in a sitting, reclining or lying posture 
(Tremblay et al., 2017). Multiple definitions have been used within the literature, however, 
the above terminology has been selected to standardise the vocabulary used (Barnes et al., 
2012; Tremblay et al., 2017). It has been proposed that engaging in a non-sedentary bout, 
between two sedentary bouts throughout the day, may be beneficial for metabolic health in 
individuals at risk of T2D, regardless of the physical activity intensity of these non-sedentary 
bouts (Henson et al., 2013). 
It is suggested from accelerometer derived data that adults spend up to 68 % of their 
waking day sedentary (Dunstan et al., 2012a), with archetypical waking hours of 16 h/day 
(Chastin et al., 2015b; Hamilton et al., 2007). These individuals spend approximately half of 
their waking day with relatively idle muscle activity (Hamilton et al., 2007). Large skeletal 
muscles such as the quadriceps, hamstrings, rectus abdominus, oblique’s, erector spinae, 
and gluteus muscles, that are required for posture changes such as sit-stand-transitions, 
subsequently become inactive. This muscular inactivity is associated with negative effects 
on cellular processes in skeletal muscle and tissue regulating risk factors including plasma 
triglycerides and high-density lipoprotein cholesterol (Hamilton et al., 2007). 
Frequent interruptions to sedentary time are suggested to be metabolically beneficial 
(Dunstan et al., 2012b). Due to oxidative stress, caused by transient exaggerated 
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postprandial spikes in glycaemia and lipids in response to muscular inactivity, a biochemical 
inflammatory cascade, endothelial dysfunction, and sympathetic postprandial hyperactivity 
may occur (Dunstan et al., 2012b). Thus, reducing the magnitude of postprandial 
hyperglycaemia is of public health interest.  
Interruptions to prolonged sitting involving light to moderate-intensity physical activity in 
bouts of 2 min every 20 – 30 min have been shown to result in suppressed postprandial 
glycaemia (Dunstan et al., 2012b; Bailey and Locke, 2015). However, most of the studies 
assessing glycaemic responses to interrupting prolonged sitting have been conducted in a 
laboratory environment (Dempsey et al., 2014; Pulsford et al., 2017; Thorp et al., 2014). 
Studies of this design may not reflect free-living transitions between sitting, standing, and 
ambulation that would occur sporadically. Thus, the application of these laboratory 
interventions to free-living conditions is limited. There is limited literature that investigates the 
effects of interrupting sitting on glycaemic responses in free-living conditions (Duvivier et al., 
2013; Duvivier et al., 2016; Duvivier et al., 2017; Duvivier et al., 2017). Participants in these 
studies were either of normal weight, overweight and obese, or had T2D. However, the 24 h 
glycaemic responses to interrupting sitting in free-living conditions has not been studies in 
overweight and obese individuals and this therefore requires investigation. This is important, 
as adiposity is a major risk factor for insulin resistance and T2D (Field et al., 2001). 
1.1 Aim 
The aim of this study was to examine 24 h interstitial glycaemic responses to interrupting 
prolonged sitting in free-living conditions in overweight and obese inactive and sedentary 
adults.  
1.2 Hypothesis 
It was hypothesised that 24 h interstitial glycaemia concentrations would be attenuated 
during a 4-day period of interrupted sitting compared with a 4-day period of uninterrupted 
sitting.  
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2. Literature Review   
2.1 Sedentary behaviour and physical inactivity  
Sedentary behaviour and physical inactivity are distinct from one another. Physical inactivity 
has been defined as a level of physical activity insufficient to meet current recommendations 
of physical activity (World Health Organization, 2010). Whereas sedentary behaviour refers 
to any characterized as any waking behaviour which expends energy at ≤ 1.5 metabolic 
equivalent of task (METs) whilst in a sitting, reclining, or in a supine position (Tremblay et al., 
2017). 
2.1.1 Physical inactivity  
An individual can be sedentary and physically active and therefore they need to be 
considered as two separate entities. Interventions designed to increase physical activity may 
be limited in reducing sedentary behaviour as individuals may feel that they have been 
sufficiently active and may rest for the remainder of the day, feeling satisfied that they have 
met physical activity guidelines (Prince et al., 2014). Furthermore, increasing physical 
activity without decreasing time spent in sedentary behaviours has shown to have no 
protective effects on health (Ekelund et al., 2016). It is proposed that a multitude of genes 
and molecular processes are inhibited by physical inactivity, which are activated by exercise 
(Owen et al., 2010a). In contrast to the above definition of sedentary behaviour, physical 
inactivity refers to not meeting specific physical activity guidelines i.e. 150 min of moderate 
aerobic physical activity, 75 min of vigorous physical activity, or a sufficient combination of 
the two intensities (World Health Organisation, 2010.) Therefore sedentary behaviour and 
physical activity can coincide during a 24 h period, for example, an office worker who sits for 
70 % of the day may also engage in sufficient levels of MVPA (Dempsey et al., 2014). 
Furthermore, the opposite can also occur, for example an individual may not engage in 
sedentary pursuits and engage in light intensity physical activity such walking, standing and 
light ambulation but not meet the recommended physical activity levels (Van der Ploeg & 
Hillsdon, 2017). Independent of meeting public health physical activity recommendations 
(150 min/week of MVPA), adverse cardiometabolic outcomes are still present when 
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prolonged bouts of sedentary behaviour, such as uninterrupted sitting occurs (Dempsey et 
al., 2014). Furthermore, it has been proposed that engaging in high levels of moderate 
physical activity (60 – 75 min/day) may negate the increased risk of mortality associated with 
high levels of un interrupted sitting (Ekelund et al., 2016). From these definitions it is clear 
that sedentary behaviour is treated as a separate and unique paradigm from physical 
inactivity (Hamilton et al., 2004; Hamilton et al., 2007; Owen et al., 2010b). 
2.1.2 Sedentary behaviour 
Sedentary behaviour refers to any  waking behaviour which expends energy at ≤ 1.5 
metabolic equivalent of task (METs) whilst in a sitting, reclining, or in a supine position 
(Tremblay et al., 2017). However, multiple definitions have been used to define sedentary 
behaviour within existing literature (Barnes et al., 2012; Tremblay et al., 2017). Sedentary 
pursuits include sitting at a desk, sitting in a vehicle and sitting watching television. Modern 
lifestyles may augment the engagement in sedentary behaviours, with technological and 
computer advancements such as automation of chores at home, and transportation trends 
potentially playing a role in the increased prevalence of sedentary behaviour (Hamilton et al., 
2007). Compared to predecessors, current environments limit physical activity and are 
conducive to prolonged sitting (Owen et al., 2010a). With these advancements in 
technologies of modern life, such as transportation, communication, and work place 
productivity, the need for physical activity has decreased since the 1960’s (Church et al., 
2011). 
 It is important to highlight that sedentary behaviour is distinct from lack of physical activity 
as it has independent effects from inactivity including metabolism, physical function and 
certain health outcomes (Venables and Jeukendrup, 2009; Edwardson et al., 2012; Proper 
et al., 2011; Van Uffelen et al., 2010).  
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2.1.3 Prolonged sitting bout  
There is much discrepancy in the literature regarding the definition of a “prolonged bout”. 
Prolonged bouts of sitting have typically been reported as being > 30 min of uninterrupted 
sitting (Dempsey et al., 2016a; Healy et al., 2013; Henson et al., 2016; Larsen et al., 2015; 
Peddie et al., 2013; Thorp et al., 2014). However, several studies have reported prolonged 
sitting bouts as > 20 min of uninterrupted sitting (Bailey and Locke, 2015; Brocklebank et 
al.,2017; Crespo et al., 2016; Dunstan et al., 2012b). Interrupting bouts of sitting every 20 
min has shown to be advantageous to metabolic health and is associated with lower post-
prandial glucose and insulin levels (Dunstan et al., 2012b). In line with the current literature, 
the mention of a prolonged bout of sedentary time will refer to > 30 min of uninterrupted 
sitting.  
2.1.4 Measuring physical activity, sedentary behaviour and physical inactivity  
Sedentary behaviour can be measured either subjectively or objectively. Subjective 
measures include self-report questionnaires, proxy report questionnaires, and diaries. 
Objective measures include accelerometer, posture monitors, heart rate/ combined sensing, 
and multi-unit monitors. Subjective measures such as diaries and questionnaires are a cost 
effective, readily available and are able to capture the type of behaviour in the context of 
which it occurs (Atkin et al., 2012). Despite the strengths identified of subjective measures, 
self-report measures consistently demonstrate poor validity, and are vulnerable to social 
influences and cultural norms (Atkin et al., 2012).  The use of objective measures such as 
accelerometry and posture monitors is increasing. Accelerometry has been widely used to 
measure sedentary behaviour and feasibility has been well established.  Posture monitors 
are widely used in sedentary behaviour research and feasibility has been indicated.  
Furthermore, the participant burden of these devices have been classed as low to moderate. 
Accelerometers can detect total sedentary time including bouts of sedentary time and breaks 
taken. Posture monitors such as activPAL, can record time spent sitting, standing, and 
posture transitions. Posture devices differ from accelerometers, as they are able to 
distinguish between sitting and standing, whereas accelerometers may miss these breaks 
from sitting if no ambulation occurs. However, for posture monitors, validation in free-living 
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conditions is lacking (Atkin et al., 2012). The activPAL is a small electronic device affixed to 
an individual’s skin on the midline of the anterior aspect of the thigh. The small device 
determines posture on the basis of thigh acceleration, including gravitational component and 
uses proprietary algorithm (Harrington et al., 2011). 
2.1.5 Prevalence of sedentary behaviour   
Sedentary behaviours are highly prevalent and data suggests the majority of time 
awake is spent in sedentary pursuits in adults (Hansen et al., 2012; Matthews et al., 2008).It 
has been reported that adults spend between 55 - 70 % of their waking day in a sedentary 
behaviour, which equates to 9 – 11 h/day  (Matthews et al., 2008; Colley et al., 2011). Sitting 
in itself is not dangerous to health, but problematic in high doses. An increase in risk of all-
cause mortality between all-cause mortality and sitting for more than 7-8 hours a day. 
Findings from prospective cohort studies report an association between self-reported sitting 
of > 8 h/day compared to < 3 h/day, and all-cause mortality in 83,034 with a follow-up period 
of 8.7 y (Inoue et al., 2008). Additionally, another prospective cohort study, by Patel (2010) 
reported an association with cardiovascular mortality and self-reported sitting timed < 3vs ≥ 
6 h/day.  
 However, an observational study of 6,329 participants suggested that adults ≥ 20 y 
spent between an average of 7.48 – 9.28 h/day sedentary (Matthews et al., 2008). Matthews 
and colleagues (2008) measured physical activity objectively via an Actigraph 
accelerometer, which measured physical activity in 1 minute epochs, with the cut-point for 
sedentary behaviour as < 100 counts/min. However, this study by Matthews et al., (2008) did 
not investigate time spent in physical activity levels; light, moderate and vigorous-intensity, 
therefore high levels of sitting and low levels of physical activity cannot be postulated from 
these data (Ekelund et al., 2016). It is important to highlight that time spent wearing the 
waist-worn accelerometer in this study was less than previously reported for waking hours in 
other national surveys (Matthews et al., 2008). 
Conversely, an average of 8.4 h/day spent sedentary has been report accelerometer 
derived data from 173 adults (53.3 ± 11.9 y) over a 7-day period (Healy et al., 2007). 
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Participants were asked to wear an Actigraph and were provided with a diary to record non-
wear and sleep times. A cut-off point of < 100 counts/minute was chosen to categorise 
sedentary (Healy et al., 2007) Observations by Healy et al., (2007) did not report patterns of 
sedentary time. Data from an observational office based study, measuring total sitting time in 
170 adults (40.1 ± 12.7 y, 24.5 ± 3.8 kg/m-2) found on workdays participants spent a 
significantly greater proportion of time in sedentary pursuits and significantly less time in 
light-intensity physical activity compared to non-working days (Clemes et al., 2014). 
Participants wore a waist-worn accelerometer, Actigraph, for 7 days with the sedentary cut-
point being <100 counts/min. On workings day, sedentary behaviours  during working hours 
accounted for 68 % of total daily sitting (Clemes et al., 2014). Furthermore, from 17:00 (on 
working days) participants were observed to steadily increase their sitting time in a linear 
fashion until participants went sleep, to reach 71 % of the waking hours sedentary (Clemes 
et al., 2014). Individuals in predominantly desk bound occupations have a high prevalence of 
sedentary behaviour  throughout the waking day and it can be postulated that those 
individuals may be at an increased risk of adverse health outcomes.  
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A limitation of with the above mentioned studies (Matthews et al., 2008; Healy et al., 
2007; Clemes et al., 2014) that used accelerometer data from waist worn devices such as 
Actigraph, are unable to determine changes in posture from sedentary to standing.  
Moreover, high cut-off points such as < 100 counts/min for sedentary time may miss periods 
of minimal ambulation that can occur throughout the day, such as filling paperwork. Light 
ambulation activities such as this has been reported to register at 60 counts/ min  (Crouter 
SE, Clowers KG, Bassett DR Jr,. 2006). Furthermore, it has been suggested that different 
cut-point used for Actigraph devices may influence estimates of physical activity intensity 
and the prevalence of meeting physical activity guideline (Loprinzi et al., 2012). As ambulatory 
physical activity is an important component of total energy expenditure, capturing this activity 
is vital to better understand and measure the prevalence of sedentary behaviours (Crouter 
SE, Clowers KG, Bassett DR Jr,. 2006). Finally, participants may fail to comply with study 
protocols as the Actigraph is not worn during sleep and requires the participants to remove 
the device just before sleeping and replace upon waking up. Time spent sedentary in the 
evening or just before sleep could be missed if the device is removed too early or replaced 
too late after waking up. Therefore, more direct measures should be used to estimate 
physical activity and sedentary levels with devices such as ActiPAL. 
2.1.6 Associations of total sedentary time with glycaemia 
 
It is thought that physical inactivity and sedentary behaviour are main factors in the onset of 
many chronic diseases (Bergouignan et al., 2011). However, these findings were derived 
from bed-rest studies, which may not reflect the level of physical inactivity of the general 
population. Nevertheless, total physical inactivity through bedrest has shown to induce the 
following: ectopic fat storage, decreased fat oxidation, lipid signalling between adipose 
tissues and muscle, and insulin resistance (Bergouignan et al., 2011). It is hypothesised that 
the influence of sedentary behaviour on metabolic and cardiovascular risk may be mediated 
through the cation of insulin, the upregulation of lipoprotein lipase activity and triglyceride 
uptake (Peddie et al., 2013).  Additionally, the aforementioned metabolic alterations are 
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more prevalent within obese populations resulting in a potential higher risk for these 
populations (Bhupathiraju, 2016). 
Total sedentary time, both objectively and subjectively measured, may be adversely 
associated with markers of cardiometabolic risk including abnormal glucose metabolism 
(Dunstan et al., 2004; Healy et al., 2008). Objectively measured free-living physical activity 
from 173 individuals (53.3 y, 27.2 kg/m-2) found a significant association between higher 
sedentary time and higher 2 h glycaemic response compared to individuals with lower levels 
of sedentary behaviour  (Healy et al., 2007). However, it is not known from data available, 
how sedentary behaviour  is accumulated throughout the waking day, which has been 
suggested to be pertinent in glucose metabolism (Dunstan et al., 2004; Healy et al., 2008). 
Observational data shows that after adjusting for potential confounders, high levels of 
sedentary behaviour were associated with significantly higher postprandial plasma 
glycaemia (Healy et al., 2008). Data from 168 participants demonstrated that individuals with 
the least interruptions to sitting had significantly higher 2 h postprandial glycaemic response 
compared to individuals with the highest frequency of interrupted sitting (Healy et al., 2008). 
Moreover, adverse glycaemic response may be associated with the duration of sedentary 
bouts, and not only the total time spent sedentary (Healy et al., 2008). Therefore, sedentary 
behaviour accumulated in uninterrupted bouts may be detrimental to glycaemic metabolism 
and potentially increase the risk of developing CVD and T2D.   
2.1.7 Associations of interruptions in sedentary behaviour with glycaemia  
It has been suggested that replacing sedentary time with standing or light intensity activity 
may assist in the prevention of major non-communicable disease (Smith et al., 2015). 
Regular ingestion of high-calorie meals, in which carbohydrate accounts for a high 
percentage of macronutrient composition, can lead to transient exaggerated postprandial 
spikes in glycaemia (Dunstan et al., 2012b). These postprandial excursions, when repeated 
throughout the day, may generate an internal environment for the pathogenesis of CVD and 
T2D (O’keefe and Bell, 2007). Elevated postprandial glycaemic response may exhibit greater 
degrees of adverse pathogens, namely oxidative stress, compared to sustained 
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hyperglycaemia (Monnier et al., 2006).  Interrupting sedentary behaviour  with light-intensity 
physical activity (LIPA) may be an effective mode for acutely reducing postprandial 
glycaemic spikes (Dunstan et al., 2012b).  
Individuals with higher levels of MVPA and increased LIPA time had significantly lower 
postprandial plasma glycaemia (Healy et al., 2008). This association was observed following 
adjustment for potential confounding factors including WC, age, sex, and wear time of 
accelerometer (Healy et al., 2008). Fewer interruptions in sedentary time are significantly 
associated with higher WC and higher post-prandial glycaemic response (Healy et al., 2008). 
However, observations in glycaemic response to sedentary behaviour  may be confounded 
by the influence of wearing activity monitors on participants behaviour, which thus may not 
reflect true habitual activities. It has previously been suggested that activity monitors may 
influence activity patterns of participants due to their awareness that they are being 
measured (Bussmann et al., 2001). Although beneficial glycaemic responses were observed 
in response to interrupting sitting with LIPA and MVPA (Healy et al., 2007), it cannot be 
determined that this is a chronic response to interrupting sitting, as participants may have 
engaged in higher volumes of MVPA and LIPA to respond to demand characteristics 
(Fahrenberg, 1996; Bussmann et al., 2001).  
Hyperglycaemia is one component of the metabolic syndrome (Alberti et al., 2005). The 
likelihood of having the metabolic syndrome increased as sedentary time duration, 
percentage of sedentary time, and average length of sedentary bout increased (Bankoski et 
al., 2011). Furthermore, the risk of insulin resistance, and dysglycaemia also decreases as 
the number of breaks from sedentary behaviour  increases (Bankoski et al., 2011). Another 
study which evaluated the associations of sedentary behaviour and glycaemic control 
detected a relationship between sedentary time and the metabolic syndrome (Bankoski et 
al., 2011). Observational data from 1,367 men and women, aged ≥ 60 y was used to 
compared fasted glycaemic response to habitual sedentary behaviour in individuals with 
metabolic syndrome and those without metabolic syndrome (Bankoski et al., 2011). Authors 
observed that individuals without metabolic syndrome had greater interruptions to sitting and 
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accumulated greater physical activity intensity during time spent sedentary compared to 
those with metabolic syndrome (Bankoski et al., 2011).  
Conversely, data pooled from the two prevention studies Project STAND (Sedentary Time 
And Diabetes; Yates et al., 2012) and the Walking Away from Type 2 Diabetes Study 
(Wilmot et al., 2011) demonstrated breaks in sedentary time, total physical activity, and 
MVPA were significantly inversely associated with adiposity measures, but not glycaemic 
measures (Henson et al., 2013). The study by Henson et al., (2013) was unable to further 
evidence previously noted beneficial glycaemic responses to interrupting sedentary 
behaviour. From observational studies, it is not possible to determine the minimum amount 
of time or intensity for interrupting sedentary behaviour that may be essential to result in 
glycaemic attenuation (Healy et al., 2008). For Healy et al., (2008) and Bankoski et al., 
(2011) the threshold that were included as interruptions to sitting were measured from ≥ 100 
counts per min for 1 min, using an accelerometer algorithm . Therefore, it may be postulated 
that if interruptions to sitting are accumulated at the lower end of the activity count threshold, 
this intensity may be insufficient to result in glycaemic improvement to interrupting sitting in 
observational studies. 
From the epidemiological studies conducted, disparities in the effectiveness of reducing 
postprandial glycaemia via interrupting sitting have been observed. Furthermore, the acute 
effects of interrupting sedentary behaviour with LIPA are short term and may not translate to 
metabolic benefit over longer time scales (Van Dijk et al., 2013). Therefore, investigation of 
glycaemic response to interrupting sitting over multiple days in those at an increased risk of 
insulin resistance and T2D is required.    
 
2.2. Cardiometabolic risk factors 
Cardiometabolic risk factors include abdominal adiposity, hypertension, dyslipidaemia, 
hyperinsulinemia and glucose intolerance. When clustering of these risk factors occurs this 
may lead to an increased risk of cardiovascular disease (CVD) and T2D (Fisher, 2006; 
Pescatello and Vanheest, 2000).  
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2.2.1 Type 2 Diabetes   
The incidence of all diabetes has reached approximately 415 million people worldwide and is 
expected to rise in subsequent years (Cho, 2016). Adults with T2D account for around 90 % 
of all diabetes cases (Health and Social Care Information Centre: National Diabetes Audit 
2012/13). The prevalence in the United Kingdom (UK) has increased by 1.74% in the years 
from 2004 to 2014, with men having higher incidences of T2D compared to women (Zghebi 
et al., 2017). Almost 3.5 million people in the UK have been diagnosed with diabetes 
(HSCIC: National Diabetes Audit 2012/13). Furthermore, the financial burden upon the 
National Health Service (NHS) is estimated to be £10 billion a year, which equates to 10 % 
of the NHS budget. Primary care is just a fraction of the cost involved, direct and indirect 
care costs combined are estimated to be £23.7 billion a year (HSCIC: National Diabetes 
Audit 2012/13), further augmenting the need for prevention of T2D.  
T2D is the outcome of interactions between ecological factors and genetic components 
that affect beta-cell function and tissue insulin sensitivity (Scheen, 2003; Kahn, 2001). Insulin 
is a polypeptide hormone produced by beta-cells within the pancreas, in response to 
circulating carbohydrates postprandially. Insulin resistance and insulin secretion defect are 
both important factors in the pathogenesis of T2D, although the mechanisms regulating the 
interaction between these two deficiencies and the sequence in which they occur remains 
unclear (Scheen, 2003). T2D differs from the autoimmune disease, Type 1 diabetes, in 
which a complete loss of insulin-producing cells from the pancreas occurs. Type 2 diabetes 
is the dysfunction of beta-cells (Kahn, 2001) and the failure of insulin to produce its 
homeostasis effect on target organs (skeletal and cardiac muscles, liver and adipose tissue), 
leading to continuous endogenous glycaemia production, despite hyperglycaemia (Ali, 
2013). T2D is clinically diagnosed when a 2 h oral glucose tolerance test (OGTT) or fasting 
plasma glucose test provides results of≥ 11 mmol/L and ≥ 7 mmol/L, respectively(American 
Diabetes Association, 2014).  
Sustained hyperglycaemia impairs-stimulated glycaemia utilisation in the skeletal muscle, 
also referred to as glycaemia toxicity (Kurowski et al., 1999) Hyperglycaemia from 
uncontrolled glycaemia regulation is known to cause oxidative stress and is recognised as a 
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causal role in the development of diabetes. Disproportional proton gradient caused by 
oxygen consumption leaks, due to high glycaemia states, producing reactive oxygen species 
(Rolo and Palmeira, 2006). Furthermore, reactive oxygen species may also be associated 
with the pathologic process of T2D (Rolo and Palmeira, 2006). Hyperglycaemia-induced 
increases in the electron transfer donors (NADH and FADH2) increases electron flux through 
the mitochondrial electron transport chain, increasing Adenosine-triphosphate and 
Adenosine-diphosphate ratio and mitochondrial membrane potential. This leads to partial 
reduction of O2 to generate reactive oxygen species (Rolo and Palmeira, 2006). Oxidative 
stress markers have been observed in non-diabetic obese individual which further supports 
the hypothesis that oxidative stress plays a role in the pathogenesis of T2D (Houstis et al., 
2006) Therefore, insulin-mediated glycaemia disposal is inhibited in individuals with T2D 
(Scheen, 2003).  Oxidative stress increases during postprandial periods, when glycaemia 
directions fluctuate rapidly, compared to sustained elevation of hyperglycaemia (Monnier et 
al., 2006). Therefore, oxidative stress is associated with the pathogenesis of diabetes via 
dysregulation of cell metabolism and homeostasis, resulting in insulin resistance in diabetics 
(Pitocco et al., 2013).  
Beta-cell dysfunction exists in individuals who are at high risk of developing the disease 
even when their glycaemia levels are still within normal range and beta-cell function 
decreases proportionally to increasing fasting glycaemia levels (Kahn, 2001; Kahn et al., 
2006).  
 
2.2.2. Cardiovascular disease  
The term cardiovascular (CVD) refers to disease of the heart and blood vessels, and is an 
umbrella term that includes coronary heart disease, stroke, cardiomyopathy, and heart 
failure (Wallace et al., 2010). CVD, and their consequential outcomes are the most 
significant health issue of the western hemisphere regarding cost and prevalence (Lloyd-
Jones et al., 2009). Moreover, in 2014 the second main cause of death in the UK was CVD 
(Bhatnagar et al., 2016). Although mortality rates in the UK are declining, the prevalence of 
14 
 
CVD for the UK is estimated to be ≥ 7 million (Bhatnagar et al., 2016). The economic burden 
to the NHS is estimated to be £9 billion per year, and indirect costs incur a further £10 billion 
a year.  
One regulatory pathophysiological aspect of the cardiovascular system includes reactive 
oxygen species which function as signals to regulate a range of processes within the 
cardiovascular system, including control of vascular muscle (Dröge, 2002). Oxidative stress, 
the disproportionate or continual imbalance between the production of reactive oxygen 
species and anti-oxidant defences, attributes to the pathogenesis of CVD (Touyz and 
Briones, 2011). Furthermore, oxidant stress mediates postprandial glycaemia and the 
response in reactive oxygen species is proportional to the increase in glycaemia 
postprandially (O’keefe and Bell, 2007). Postprandial oxidative stress may generate an 
increases in inflammation, and vasoconstriction of blood vessels, and increases oxidation of 
low-density lipoproteins, which may lead to atherosclerosis in T2D patients and non-diabetic 
individuals (Ceriello and Motz, 2004; Ferreira et al., 2004; Weissman et al., 2006). 
2.2.3 Risk Factors for cardiometabolic disease and type 2 diabetes 
Risk factors for CVD and T2D include visceral obesity, dyslipidaemia, hyperglycaemia, and 
hypertension (Alberti et al., 2005).  The thresholds for risk factors are as follows: visceral 
obesity as measured by waist circumference (WC)  ≥ 94 cm and ≥ 80 cm for men and 
women respectively; raised triglycerides > 1.7 mmol/L; reduced HDL < 1.03 mmol/L and < 
1.29 mmol/L for men and women respectively; raised blood pressure systolic ≥ 130 mm Hg 
and diastolic ≥ 85 mmHg; raised fasting plasma glycaemia ≥ 7 mmol/L (Alberti et al., 2005); 
and 2 h postprandial glycemia 7.8 -11.0 mmol/L (World Health Organisation, 1999).  
2.2.4 Overweight and obesity as a risk factor for cardiovascular disease and type 2 
diabetes 
Obesity is a major risk factor for T2D with trends and prevalence and incidences of T2D 
closely emulating those of obesity. Analysis of epidemiological found that the majority of the 
increase in T2D is due to the increased prevalence of obesity, with 85 % of those with T2D 
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being overweight or obese (Bhupathiraju, 2016). Individuals who are overweight (BMI ≥ 25.0 
to ≤ 29.9 kg.m2) may be at an increased risk of developing T2D and CVD than their healthy 
weight counterparts (Field et al., 2001). Obese adults with a BMI ≥ 30.0 kg.m2 may have 
further increased risk of developing T2D and CVD (Field et al., 2001). Individuals with a BMI 
≥ 35 km.m2 are 20 times more likely to develop T2D over a 10 y period compared to those 
with a BMI ≤ 25.0 kg.m2 (Field et al., 2001).  
Obesity is a chronic metabolic disease that has a substantial influence on the CVD system 
(Poirier & Eckel., 2002). Obesity contributes to an array of structural and functional 
adaptations to the cardiovascular system. These include; lower cardiac output, augmented 
peripheral resistance, left ventricular mass and left ventricular wall thickness and a 
deteriation in left ventricular systolic function (Bastien et al., 2014). Furthermore, obesity is 
known to affect coronary risk indirectly through its effect on related comorbidities such as 
dyslipidaemia, hypertension, endothelial dysfunction and inflammation, and glucose 
intolerance (Wilson et al., 2002).  
In most obese patients, obesity is associated with a low-grade inﬂammation of white adipose 
tissue resulting from chronic activation of the innate immune system and which can 
subsequently lead to insulin resistance, impaired glucose tolerance and even diabetes 
(Bastard et al., 2006). For obesity and insulin resistance to be associated with T2D, beta-
cells must be unable to compensate wholly for attenuated insulin sensitivity (Kahn et al., 
2006; Kahn, 2001). However, obesity alone can cause some level of insulin resistance 
(American Diabetes Association, 2014). For instance, in obese individuals adipose tissue 
releases increased amounts of free fatty acids, glycerol, hormone, and pro-inflammatory 
cytokines that are factors involved in the development of insulin resistance (Kahn et al., 
2006). One theory suggests that limited ability of subcutaneous fat depots to store excess 
energy intake results in an excess of electron flux to intra-subcutaneous abdominal adipose 
tissue and abnormal sites, including liver and skeletal muscle (SeppäLä-Lindroos et al., 
2002). An accretion of ectopic fat (desposition of lipids within cells of non-adipose tissues, 
which typically only store small amounts of fat) distribution in turn leads to metabolic 
dysfunction in the above mentioned organs (SeppäLä-Lindroos et al., 2002). Insulin 
16 
 
resistance is correlated with intrahepatic fat or “fatty liver”, and increased intramyocellular fat 
in the liver and skeletal muscle, respectively (Sinha et al., 2002; Shulman, 2014). Non-
diabetic individuals with impaired fasting glycaemia and/or impaired glycaemia tolerance 
postprandially have increased risk of T2D and CVD (American Diabetes Association, 2014).  
Sedentary behaviour or prolonged sitting may be conspicuous in the development of these 
detritus metabolic and cardiometabolic risk profiles. It is proposed that the cumulative effect 
of too much sitting over time may contribute to shifting energy balance towards weight gain 
and obesity (Swartz et al., 2011). Observational research suggests higher total sitting time 
and sitting time accumulated in prolonged bouts (> 30 min) are associated adversely with 
cardiometabolic risk profiles, and with premature death from cardiovascular disease and all 
causes. It is proposed a mechanistic contender underlying these associations is lack of 
muscle contractile activity. A lack of skeletal muscle activity may lead to a reduction 
in skeletal muscle glucose uptake via reduced translocation of GLUT4 to the cell surface and 
lowered efficiency of insulin (Homer, Owen, & Dunstan, 2018). Although results from meta-
analysis and systematic review by Campbell et al., (2017) indicated no association with 
sedentary behaviour and obesity. Furthermore, Campbell and colleagues postulated that the 
harmful effects of sitting on cardiometabolic risk are likely mediated through mechanisms 
other than a direct effect on obesity (Campbell et al., 2017).  
Waist circumference is suggested to be a more valid indicator of cardiometabolic disease 
risk compared with BMI (Janssen et al., 2004). The recommended thresholds, highlighted 
above, are derivative from WC that are correlated with a BMI ≥ 30 kg.m2 in relation to 
cardiometabolic risk (Health, 1998). Moreover, WC is associated with an increased risk of 
cardiometabolic disease and T2D (American Diabetes Association, 2014). Additionally, WC, 
as a measure of fat distribution around the abdominal region, is effective and economical at 
ascertaining increased adiposity measurements compared to BMI (American Diabetes 
Association, 2014). It is proposed that WC can identify individuals at a greater 
cardiometabolic risk than using BMI alone (American Diabetes Association, 2014) and the 
relationship between health outcomes and WC has less variability compared to BMI 
(Visscher et al., 2001). Epidemiological studies have found WC to be a strong correlate of 
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T2D, and independent of BMI (Janssen et al., 2004). Moreover, abdominal obesity is 
associated with postprandial glycaemia and impaired fasting glycaemia (American Diabetes 
Association, 2014). Therefore, it can be postulated that WC is a greater predictor of adverse 
health outcomes compared to BMI alone.  
2.2.5 Postprandial glycaemia as a risk factor cardiovascular disease and type 2 
diabetes 
Seemingly healthy populations with impaired glycaemia metabolism, or dysglycaemia, are at 
an increased risk of a cardiac event and diabetes onset (Bergman et al., 2013). 
Dysglycaemia has been defined previously as fasting glycaemic concentraions between 5.6 
and 6.1 mmol/L (Gerstein, 2010). However, it has also been suggested that dysglycaemia is 
a fasting glycaemic concentration of ≥ 6.1 mmol/L (Takeno et al., 2008). Elevated fasted and 
postprandial glycaemia concentrations in non-diabetic, healthy populations are risk markers 
for CVD (Levitan et al., 2004). Impaired fasting and postprandial glycaemic response have 
heterogeneous pathogenesis and therefore may contribute to different rates of progression 
to T2D (Nathan et al., 2007). Additionally, with non-diabetic populations, fasting blood 
glycaemia concentrations are modestly and non-linearly associated with risk of vascular 
disease (Emerging Risk Factors Collaboration, 2010). Conversely, an epidemiological study 
observed impaired fasting glycaemia to not be a risk factor for CVD mortality (Tominaga et 
al., 1999).  
However, epidemiological studies have revealed postprandial hyperglycaemia to better 
predict future CVD mortality compared to fasting hyperglycaemia in diabetics and 
normoglycaemic individuals (Mah and Bruno, 2012). Furthermore, elevated postprandial 
glycaemic response may be a stronger risk factor for CVD and greater indicator of CVD and 
T2D risk, compared to fasting hyperglycaemia (Bonora and Muggeo, 2001). Acute 
hyperglycaemia exacerbates vascular endothelial dysfunction in individuals with chronic 
hyperglycaemia and transiently impairs vascular function in healthy individuals (Mah and 
Bruno, 2012). Non-diabetic individuals with moderately higher glycaemic responses (< 7 
mmol/l)  to an OGTT have an increased cardiovascular risk then their normoglycaemic 
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(fasting blood glycaemia 3.9 – 5.6 mmol/L) counterparts (World Health Organisation, 1999; 
Hermans et al., 1999).  
Sustained postprandial hyperglycaemic bouts (≥ 7 mmol/L) are associated with micro and 
macrovascular damage, and damage to internal organs. However, adverse health outcomes 
may not develop until postprandial glycaemic values exceed ≥ 11 mmol/L (Stratton et al., 
2000). Therefore, identifying and reducing consistently elevated postprandial glycaemic 
concentrations in non-diabetic populations is of public health interest to attenuate the risk of 
T2D. 
2.2.6 Sedentary behaviour as a risk factor for cardiovascular disease and type 2 
diabetes 
Physical inactivity and large volumes of sedentary time are independently associated with 
increased cardiometabolic morbidity and mortality in a dose-dependent manner (Bassuk and 
Manson, 2005). Adults at a high risk of T2D (BMI ≥ 25kg/m2, high waist circumference, low 
physical activity levels, and being ≥ 40 y, or ≥ 25 y,fand some black and minority ethnic 
groups), the time spent sedentary is strongly and adversely associated with cardiometabolic 
health and may be a more important indicator of poor health compared to moderate–
vigorous physical activity (MVPA) levels (Henson et al., 2013; Harding et al., 2006).  
Active individuals that engage in the recommended intensity and duration (150 min/week 
MVPA) of physical activity are not protected against the adverse health outcomes associated 
with sedentary behaviour (Ekelund et al., 2016). Although meeting the recommended 
physical activity guidelines does not eliminate mortality risk, a smaller increase was 
observed in those that did meet these recommendations compared to those who engaged in 
~ 35 min of moderate intensity physical activity per week (Ekelund et al., 2016). However, 
those engaging in high volumes (60-75 min/day) eliminate the increased mortality risk 
associated with high sitting time (Ekelund et al., 2016). Therefore, interventions in inactive 
individuals need further investigation to attenuate the increased mortality risk associated with 
sedentary behaviour. High volumes of sitting, typically assessed as total daily sitting or time 
spent viewing television, have been associated with increased risk of all-cause mortality. 
19 
 
Data pooled from 16 studies, analysing over 1 million individuals suggests that individuals 
who spend ≤ 4 h/day and engaged in low levels of physical activity (≤ 2.5 MET-hour/week) 
had higher all-cause mortality rates compared to individuals who sat ≤ 4 h/day and engaged 
in high levels of physical activity (≥ 35.5 MET-hour/week) (Ekelund et al., 2016). However, 
data  suggests that individuals who sat 8 h/day and engaged in high levels of physical 
activity had increased risk of all-cause mortality compared to individuals who sat ≤ 4 h/day 
and engaged in high levels of physical activity (≥ 35.5 MET-hour/week) (Ekelund et al., 
2016). Therefore, high levels of physical activity may protect against adverse health 
outcomes of sedentary behaviour.  
Associations of CVD mortality risk with daily sitting are estimated to be 2.7 times greater in 
those with high levels of sitting compared to those with low levels of sitting (Weller and 
Corey, 1998). Furthermore, uninterrupted sitting, an accumulation of sedentary time in an 
extended continuous bout (Tremblay et al., 2017), predicted increased CVD risk in 73,743 
women independent of age and recreational energy expenditure (Manson et al., 2002). 
However, when the association between biomarkers of CVD risk and weekly time spent TV 
viewing was investigated there were no significant relationships with low density lipoprotein 
cholesterol, high density lipoprotein cholesterol, triglycerides, insulin, C-peptide, and 
glycated haemoglobin over an 8 y period (Fung et al., 2000). 
 Commuting to work via a car is classified as a sedentary activity. Owning a car and/or TV 
is associated with increased risk of acute myocardial infarction (Van Craenenbroeck and 
Conraads, 2012). A longitudinal cohort study followed participants for 21 y and measured the 
associations between sedentary behaviours and cardiovascular disease mortality rates. Out 
of 7,700 men, those who reported sitting in a car for > 10 h/week had a 50 % increased risk 
of dying from  CVD compared to those who reported < 4 h/week (Warren et al., 2010). When 
reported hours for sedentary behaviours were combined (viewing TV and sitting in a car), 
those that reported > 23 h/week of sedentary behaviour had a 37 % increased risk of CVD 
mortality compared to those that had reported < 11 h/week (Warren et al., 2010). 
Additionally, a cross sectional study showed time spent in cars to be associated with higher 
BMI, WC, and cardiometabolic risk score (Hoehner et al., 2012). 
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Furthermore, sedentary behaviour may contribute to weight gain and obesity which 
increases the risk of developing T2D and CVD (Field et al., 2001). A recent systematic 
review reported that only WC and sedentary behaviour are significantly associated with one 
another whereas body weight, BMI, and % of body fat were not associated with sedentary 
behaviour (Campbell et al., 2017). It was reported that each 1 h/day increase in sedentary 
behaviour  resulted in 0.02 cm WC increase over five years (Campbell et al., 2017).  
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2.3 Experimental research on glycaemic response to interrupting sitting  
Presently, experimental evidence suggests that both LIPA and MVPA interruptions to sitting have 
acute beneficial effects on glycaemic control (Chastin et al., 2015a). The evidence for postprandial 
glycaemic attenuation from interrupting prolonged sedentary behaviour has largely been observed 
over an acute period typically lasting up to one day (Bailey et al., 2015; Dempsey et al., 2014; 
Dunstan et al., 2012b; Pulsford et al., 2017). However, some studies have investigated 
postprandial glycaemic response over longer durations of 3 - 8 days (Duvivier et al., 2016; Duvivier 
et al., 2013; Thorp et al., 2014; Larsen et al., 2015; Altenburg et al., 2016). The details of such 
studies are outlined in Table 1 and are discussed in the following sections in more detail. 
  A recent study examined the response of postprandial glycaemia in response to 
interrupting sitting over one and three days, and found that there may be different pathways in 
which postprandial glycaemic concentration is reduced (Bergouignan et al., 2016). Interrupting 
prolonged sitting with light and moderate-intensity physical activity bouts over one day have been 
suggested to stimulate contraction-mediated glycaemia uptake pathways (Bergouignan et al., 
2016). Furthermore, moderate-intensity physically activity bouts over one day may increase 
GLUT4 translocation, glycogen synthesis, and oxidative phosphorylation (Bergouignan et al., 
2016). Additionally, LIPA interruptions over three days have been suggested to stimulate 
contraction-mediated and insulin-mediated glycaemia uptake pathway and GLUT4 translocation 
(Bergouignan et al., 2016). 
2.3.1 Laboratory studies on glycaemic response to interrupting sitting   
2.3.2 Interrupting prolonged sitting with walking  
Research has demonstrated that interrupting sitting with 2 min bouts of light intensity walking 
every 20 min for 5 – 7 h results in a decrease in glucose total area under the curve (AUC) and 
incremental area under the curve (iAUC) by 9 % to 55 % compared with uninterrupted sitting in 
laboratory environments (Brocklebank et al., 2017; Pulsford et al., 2017; Dunstan et al., 2012b; 
Larsen et al., 2015; Bailey and Locke, 2015). However, the greatest reduction seen was when 
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interstitial glycaemia concentrations were measured over 5 h in response to a test meal drink in a 
mixture of healthy weight, overweight, and obese adults (Brocklebank et al., 2017). In comparison, 
lower glycaemia attenuation has been observed in obese and overweight individuals when 
glycaemia was measured via capillary and venous blood samples in response to an OGTT or 
standardised mixed meals (Dunstan et al., 2012b; Pulsford et al., 2017; Larsen et al., 2015; Bailey 
and Locke, 2015). This suggests that analysing singular capillary of venous blood samples over 
multiple periods (e.g. every 30 min) over a 2 h postprandial period may miss potential important 
glycaemic responses in overweight and obese individuals and underestimate attenuation in 
response to interrupting sitting time. Therefore, measuring glycaemic response with samples at a 
higher frequency (e.g. every 15 min) over a longer duration, may provide deeper insight into 
postprandial glycaemic response to interrupting sitting.  
 Overweight and obese adults and those diagnosed with type 2 diabetes may have the 
greatest magnitude in attenuation of postprandial glycaemic response to interrupting sitting with 
light intensity walking (Dempsey et al., 2016a; Dunstan et al., 2012b; Henson et al., 2013; Larsen 
et al., 2015). One such study instructed overweight and obese participants to rise from a seated 
position every 30 min and walk on a treadmill for 3 min at 3.2 km.h-1 and then return to the seated 
position (Dempsey et al., 2016a). Participants performed this posture change 12 times during 7 h, 
totalling 36 min of light-intensity walking (Dempsey et al., 2016a). This physical activity intensity 
and frequency attenuated postprandial plasma iAUC glycaemic response by a statistically 
significant 38.8 % compared to 7 h of uninterrupted sitting (Dempsey et al., 2016a). Furthermore, 
walking at 3.2 km.h-1 for 2 min every 20 min over 5 h resulted in a significant reduction in positive 
iAUC postprandial glycaemia in overweight and obese participants by 24.1 %  (Dunstan et al., 
2012b). Furthermore, a 9 % reduction in glycaemia AUC in response to light intensity walking for 2 
min every 20 min was observed in inactive middle-aged men (Pulsford et al., 2017). However, 
these studies only investigated the acute effects of interrupting sitting on glycaemic responses over 
a period of one day (Dempsey et al., 2016a; Dunstan et al., 2012b; Pulsford et al., 2017), 
therefore, the persistent or carryover effects of light intensity walking in overweight and obese 
individuals cannot be postulated. 
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The persistent effects of interrupting sitting with light intensity walking has been examined over a 
24 h period (Crespo et al., 2016). Nine overweight and obese individuals interrupted sitting with 
four bouts of 10 min walking, two bouts of 20 min walking, and two bouts of 30 min walking at 1.0 
mph over an 8 h interval, totalling 2.5 h of light intensity walking (Crespo et al., 2016). Twenty-four-
hour  interstitial glycaemia was measured to obverse three, 2 h postprandial episodes; breakfast 
between 0815-0845, lunch between 1200-1230 and dinner at participants elected time but 
standardised between conditions, and cumulative 6 h postprandial glycaemic response and 
glycaemic responses during sleep (Crespo et al., 2016). A 24 % decrease in 6 h postprandial 
glycaemia iAUC was found for light intensity walking compared to uninterrupted sitting and these 
glycaemic benefits persisted overnight (Crespo et al., 2016). Furthermore, a recent study 
investigated the 24 h carryover effects of interrupting sitting with light intensity walking over 7.5 h 
on postprandial glycaemic responses (Henson et al., 2016). On day one, participants were asked 
to interrupt sitting with 5 min of walking at a self-perceived light intensity on a treadmill (rate of 
perceived exertion between 10 – 12) every 30 min. At 0800 h the next day, participants returned 
and remained seated for 7.5 h. Postprandial iAUC glycaemic response was significantly reduced 
by 28 and 17 % on day one and two, respectively (Henson et al., 2016). Another study explored 
the cumulative effects of three consecutive days of interrupting sitting with light intensity walking on 
postprandial glycaemic response compared to uninterrupted sitting (Larsen et al., 2015). Nineteen 
overweight and obese individuals were instructed to interrupt their sitting with treadmill walking at 
3.2 km.h-1 for 2 min every 20 min over a 6 h period for three days. Postprandial iAUC for glycaemia 
reduced by 32 and 31 % on day one and three, respectively for light-intensity walking (Larsen et 
al., 2015). However, no effect of time was found across the three-day protocol. Therefore, three 
accumulative days of interrupting sitting does not enhance, but sustains, the magnitude of the 
reduction in plasma glycaemia concentrations, compared to one day of interrupting sitting. 
Data indicates that interrupting prolonged sitting has the highest impact on metabolic health in 
individuals with strong risk factors for T2D, such as obesity, physical inactivity, and dysglycaemia 
(Liu, 2015). Interrupting sitting for 3 - 5 min every 30 min with moderate-intensity walking in 
overweight and obese individuals, and overweight and obese individuals with T2D, have resulted in 
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a higher attenuation in glycaemic response compared to when interrupting sitting occurred for 2 
min every 20 min (Peddie et al., 2013; Dunstan et al., 2012b; Dempsey et al., 2016a). Therefore, 
the frequency and time spent in light-intensity activity may be an important factor for glycaemic 
reduction in overweight and obese individuals. From the current literature, it appears that both light 
and moderate walking intensities attenuate postprandial glycaemia when interrupting sedentary 
behaviour, and thus both should be used in protocols aimed at reducing glycaemic responses.   
2.3.3 Breaking up sitting with standing 
Another method of interrupting prolonged sitting for postprandial glycaemic benefits is with 
standing. 
However, a study examining postprandial glycaemic response to interrupting sitting with standing 
found no significant difference in glycaemia AUC compared to uninterrupted sitting (Pulsford et al., 
2017) Participants were instructed to interrupt their sitting for 2 min bouts of standing every 20 min 
over a duration of 7 h (Pulsford et al., 2017). Furthermore, interrupting sitting with standing for 2 
min bouts every 20 min over a 5 h period resulted in no significant for difference for glycaemia 
iAUC compared to uninterrupted sitting and light walking compared to uninterrupted sitting (Bailey 
and Locke, 2015). For both these studies participants were of a normal healthy weight (Pulsford et 
al., 2017; Bailey and Locke, 2015) suggesting that interrupting sitting with standing for healthy 
weight individuals may not a great enough metabolic stimulus to reduce postprandial glycaemic 
response.  
However, In overweight and obese individuals standing results in significant glycaemic 
attenuations (Henson et al., 2016; Thorp et al., 2014). Twenty-two overweight and obese 
dysglycaemic postmenopausal women interrupted sitting with standing for 5 min every 30 min over 
a 7.5 h period Henson, 2016 #40}. Glycaemia iAUC reduced by 34 %, compared to uninterrupted 
sitting  during this period and was also reduced by 19 %the following day (Henson et al., 2016). 
Furthermore, a significant decrease of 11.1 % was found for glycaemic iAUC response in 
overweight and obese adults when sitting was alternated with standing every 30 min, totalling 4 
hours over 8 h (Thorp et al., 2014). Glycaemic response to interrupting sitting was similarly 
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effective on day 1 and day 5 of this protocol, suggesting that there is no cumulative effect of 
interrupting sitting with standing (Thorp et al., 2014).  
Conversely, no significant difference for postprandial glycaemia was observed in overweight and 
obese individuals when prolonged or intermittent standing was performed over 8 h (Hawari et al., 
2016). Participants completed three protocols in a randomised cross over design: uninterrupted 
sitting for 8 h, sitting and prolonged standing for 15 min every 30 min totalling 4 h/day, and sitting 
with intermittent standing 10 times every 30 min totalling 4 h/day (Hawari et al., 2016). This 
suggests that standing alone as a mode of interrupting sitting, irrelevant of the frequency of sit to 
stand transitions, may be unable to attenuate postprandial glycaemic responses in overweight 
obese individuals. 
There is conflicting research regarding the benefits of interrupting sitting with standing on 
postprandial glycaemia. One explanation for the attenuation of postprandial glycaemia may be 
standing duration. Standing for 28 and 36 min, accrued in bouts of 2 min every 20-min, resulted in 
no significant difference in postprandial glycaemia over a 5 and 7 h period, respectively (Bailey and 
Locke, 2015; Pulsford et al., 2017). However, standing for an accumulated 60 min and 240 min, 
resulted in significant glycaemic reduction over a 7.5 and 8 h period, respectively (Henson et al., 
2016;Thorp et al., 2014). It is important to note that significant attenuation was observed in 
overweight and obese individuals who are at an increased risk of dysglycaemia and T2D (Liu, 
2015)., compared to no benefit being observed in healthy weight individuals. Therefore, in 
dysglycaemic individuals, it could be postulated that significant beneficial impacts of standing on 
postprandial glycaemia may be dependent on standing duration.  
2.3.4 Interrupting sitting with resistance exercise 
There a limited number of studies (see Table 1) that investigate the effects of interrupting sitting 
with resistance exercise on glycaemic response (Dempsey et al., 2016a; Fletcher et al., 2017). It 
has been proposed that performing body weight resistance exercises utilises lager muscle groups 
compared to walking and standing and therefore may promote an increased energy expenditure 
and higher glucose uptake(Fletcher et al., 2017).  
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Thirteen adolescents (16.4 ± 1.3 y, BMI 20.6 ± 2.5 kg.m-2) completed four experimental 
conditions with a minimum of 24 h wash out period between conditions (Fletcher et al., 2017). 
Participants were instructed to perform 2 min of body weight resistance exercises (half squats, calf 
raises, knee lifts, and step ups) each for 30 s (Fletcher et al., 2017). Four experimental conditions 
were as follows: two high energy diet conditions; uninterrupted sitting for 6 h, interrupting sitting 2 
min of body weight resistance exercises (half squats, calf raises, knee lifts, and step ups) each for 
30 s completed every 18 min, and two standard energy diet conditions with either uninterrupted 
sitting or interrupting sitting with bodyweight resistance exercises. Postprandial glycemic response 
was measured over three-time periods; 2 h post the first meal, 2 h post the second meal, and over 
the entire 6 h trial duration (Fletcher et al., 2017). 
Glycaemic response was measured via an interstitial continuous glucose monitor (Fletcher et al., 
2017). Compared to sitting conditions, interrupting sitting conditions resulted in a significant 
reduction of 36.0 mmol.L.h and 35.9 mmol.L.h for iAUC for the first meal. However, this reduction 
was no longer significant over the 6 h period between sitting conditions and interrupting sitting 
conditions. However, this finding was observed in adolescents of normal weight, therefore they 
may have been more insulin sensitive and the effects of puberty may have increased postprandial 
glycaemic response variability within and between participants (Fletcher et al., 2017). 
In adults with T2D, simple resistance exercises (body weight half squats, calf raises, gluteal 
contractions and knee raises) when performed for 3 min every 30 min resulted in a 39.2 % 
reduction in glycaemia iAUC compared to uninterrupted sitting (Dempsey et al., 2016a). 
Participants performed these resistance exercises in nine, 20 s exercise segments (Dempsey et 
al., 2016a). Twenty-four inactive overweight and obese participants with T2D completed three 8 h 
conditions; uninterrupted sitting, sitting plus 3 min bout of light-intensity walking (3.2 km h-1) 
interruptions to sitting every 30 min, and sitting with interruptions for 3 min consisting of simple 
resistance activities interruptions every 30 min. Simple resistance activities included; alternating 
between body weight half-squats, calf raises, gluteal contractions, and knee raises. The 3 min was 
divided into a total of nine 20-s movement segments. This sequence was selected to maximise 
continuous muscle activation over the 3-min period. Resistance type exercises have been 
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suggested to use lager muscle groups and increase muscle activity, compared to sitting. Therefore 
simple resistance activities could provide a stimulus for increased energy expenditure, resulting in 
increased glycaemic uptake and an postprandial glycaemic reduction (Tikkanen et al., 2013). 
Therefore, performing simple resistance exercises that utilise large muscles and potential 
increased glucose uptake, may be beneficial to postprandial glycaemic response to interrupting 
sitting. 
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Table 1 Summary of studies examining glycaemic responses to prolonged sitting and interrupting sitting in laboratory conditions  
Reference Populations Study design/ Outcomes Methods Findings 
(Bailey and 
Locke, 2015) 
10 non-obese adults (7 
men, 3 women) 
Randomised cross-over  
Glycaemic outcome: 
Capillary glycaemia 
(fasting and hourly),  
1. Uninterrupted sitting: 5 h 
uninterrupted sitting 
2. Stand: interrupting sitting 
every 20 min for 2 min 
3. Walk: interrupted sitting 
every 20 min for 2 min with 
light-intensity walking  
Diet: x 2 drinks totalling 80.3 
g CHO 
LW vs SIT  
5 h blood glucose iAUC 
by 15.9 %  
STAND vs SIT 
No significant difference 
LW vs STAND  
5 h blood glucose iAUC 
by 16.5 %  
(Brocklebank et 
al., 2017) 
17 (13 complete data 
sets) 
Age: 54.4 ± 5.1 y 
BMI: 28.0 ± 4.5 kg/m2 
WC: 95.3 ± 10.5 cm 
Setting: participants 
workplace  
Randomised 3-period, 3-
treatment crossover  
24 h washout between 
condition days 
Activity monitoring: 
activPAL and 
ActivGraph (from start of 
trial 1 until end of trial 3)  
Glycaemic outcomes: 
Postprandial interstitial 
glycaemia concentration: 
 
1. Uninterrupted sitting: 5 h 
uninterrupted sitting 
2. Stand:  interrupted sitting 
every 20 m and stood       
still for 2 min, for 5 h. 
3. Walk: interrupted sitting 
every 20 min with 2 min of 
self-perceived light intensity 
walking (RPE 9) for 5 h.  
Diet: x2 200 mL drink (600 
kcal, 73.6 g CHO, 23.6 g 
protein, 23.2g fat)  
SIT vs. LW 
˅ 5 h Glucose  
iAUC by 55.5 %  
SIT vs LW vs STAND 
Glucose iAUCt no 
significant difference  
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Reference Populations Study design/ Outcomes Methods Findings 
(Dempsey et al., 
2016a) 
24 (14 men, 10 
women) with type 2 
diabetes 
Age: 62 ± 6 y 
BMI: 33.0 ± 3.4 kg/m2  
WC Not reported 
Setting: Laboratory  
Randomised cross-over 
6 – 14 washout between 
condition days 
Activity monitoring  
ActiGraph – sedentary 
time 
Glycaemic outcomes:  
Venous glycaemia 
(fasting and postprandial 
– 30 min intervals) 
1. Sitting 7 h  
2. Sitting and 12 light intensity 
walking (3.2 km.h) bouts for 
3 min, every 30 min 
(totalling 36 min) 
3. Sitting and 12 simple 
resistance activities (SRA) 
bouts for 3 min, divided into 
9 segments lasting 20 s, 
(totalling 36 min)  
Diet: Standardised meal (12 – 
15 % protein, 55 – 58 % 
CHO, 29 – 31 % fat, 822.9 ± 
124.3 kcal/meal)  
LW vs. SIT 
˅ 7 h blood glucose iAUC 
by 38.8 % 
 SRA vs. SIT 
˅ 7 h blood glucose iAUC 
by 39.2 % 
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Reference Populations Study design/ Outcomes Methods Findings 
(Crespo et al., 
2016) 
9 (7 men, 2 women)t  
Age: 30 ± 15 y 
BMI: 29 ± 3 kg.m-2 
WC: Not reported 
Setting: Laboratory, 
stimulated office 
environment 
Randomised cross over  
4 consecutive weeks 
7 day wash out days 
between conditions 
Activity monitoring: 
ActivPAL, GENEActiv, 
Bioharness 
Glycaemic outcomes: 
24 h Postprandial 
interstitial glycaemia – 5 
min intervals 
1. Sitting 8 h  
2. Sitting and standing for 10 
min (x 4) 20 min (x 2) and 
30 min (x 2) (totalling 2.5 h) 
3. Sitting and cycling at 20 W  
for 10 min (x 4) 20 min (x 2) 
and 30 min (x 2) (totalling 
2.5 h) 
4. Sitting and walk at 1.0 mph 
or 10 min (x 4) 20 min (x 2) 
and 30 min (x 2) (totalling 
2.5 h) 
 
STAND vs SIT  
5 % ˅ 24 h interstitial 
glucose AUC 
5 % ˅ 6 h postprandial 
interstitial glucose iAUC 
CYCLE vs SIT  
No significant difference 
in 24 h interstitial glucose 
AUC 
11 % ˅ 6 h postprandial 
interstitial glucose iAUC 
WALK vs SIT  
7 % ˅ 24 h interstitial 
glucose AUC 
8 % ˅ 6 h postprandial 
interstitial glucose iAUC 
 
 
Dunstan et al., 
2012 
19 (11 men, 8 women) 
Age 54 ± 5 y 
BMI 31 ± 4 kg/m2 
Setting: Laboratory 
Randomised 3-period, 3-
treatment cross-over 
Minimum 6 day washout  
Activity monitoring - 
ActiGraph 
Glycaemic outcomes: 
Venous plasma 
glycaemia (fasted and 
postprandial)  
1. Sitting 5 h 
2. Sitting and14 light-intensity 
walking (3.2 km/h) bouts of 
2 min, every 20 min, totalling 
28 min 
3. Sitting and moderate-
intensity walking (5.8 – 6.4 
km/h) bouts of 2 min, every 
20 min, totalling 28 min 
LW vs SIT 
˅ 5 h positive glucose 
iAUC by 24.1 % 
MW vs SIT 
˅ 5 h positive glucose 
iAUC by 29.6 % 
31 
 
Reference Populations Study design/ Outcomes Methods Findings 
(Fletcher et al., 
2017) 
13 adolescences 
Age: 16.4 ± 1.3 y 
BMI: 20.6 ± 2.5 kg/m2 
WC:  
Setting: Laboratory  
Cross-over factorial 
randomised trial 
Minimum 1 day washout 
Glycaemic outcomes: 
Fasted and postprandial 
interstitial glycaemic 
response  
1. Sitting 6h (high energy diet) 
2. Sitting and body weight 
resistance exercises: body-
weight resistance exercises 
and included 30- 
3. s half squats, 30-s calf 
raises, 30-s knee lifts and 
30-s step-ups, totalling 18 
min (high energy diet) 
4. Sitting 6 h (standard energy 
diet) 
5. Sitting and body weight 
resistance exercises: body-
weight resistance exercises 
and included 30-s half 
squats, 30-s calf raises, 30-s 
knee lifts and 30-s step-ups 
totalling 18 min (standard 
energy diet) 
INT SIT vs SIT  
1st meal –  ˅ 36 mmol/L/h 
glucose iAUC  
2nd meal - ˅ 35.9 
mmol/L/h glucose iAUC  
Total 6 h – No significant 
difference for glucose 
AUC   
HE vs SE 
1st meal –  ˅ 55 mmol/L/h 
glucose iAUC  
Total 6 h – ˅ 75.7 
mmol/L/h glucose iAUC 
(Hawari et al., 
2016) 
10 (men) 
normoglycemic 
overweight/ obese 
Age: 33.0 ± 13.0 y 
BMI: 28.3 ± 2.8 kg/m2 
WC: 100.2 ± 9.5 cm 
Setting: 
Randomised cross-over 
Minimum 7 day washout   
Glycaemic outcomes: 
Venous glycaemia 
concentration (fasted 
and postprandial) 
 
1. Sitting (SIT): 8 h   
2. Sitting and prolonged 
standing: 8 h (16 x 15 min 
bouts of standing, every 30 
min, totalling 4 h) 
3. Sitting and intermittent 
standing: 8 h (160 x 90 sec 
standing followed by 30 sec 
sitting) 
Diet: Standardised meal  
No significant difference 
for blood glucose 
between 3 trials  
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Reference Populations Study design/ Outcomes Methods Findings 
(Henson et al., 
2016) 
22 (women) 
postmenopausal  
Age: 68.6 ± 4.7 y 
BMI: 32.9 ±4.7 kg/m2 
WC: 102.0 ±9.0 cm 
Setting: 
 
Balanced incomplete 
block design 
(participants competed 2 
of the 3 conditions) 
Day1. 22 participants 
completed 
Day 2. 17 participants 
completed 
Washout between 
conditions 7 and 22 days  
Glycaemic outcome: 
Plasma glycaemia, 
(fasting and 
postprandial)  
 
Day 1. 
1. Sitting – 7.5 h  
2. Sitting 6.5 h and 12 
standing bouts of 5 min 
every 30 min, totalling 60 
min 
3. Sitting 6.5 h and 12 bouts 
of light intensity walking 
(1.5 – 4.0 km/h) for 5 min 
every 30 min, totalling 60 
min -  
Day 2.  
1. Sitting, uninterrupted 7.5 h  
Diet: standardised breakfast 
and lunch (both 58 % fat, 26 
% CHO, and 16 % protein. 15 
min to consume) 
 
 
Day 1.  
STAND vs SIT 
˅ glucose iAUC by 34 % 
LW vs SIT 
˅ glucose iAUC by 28 % 
No significant differences 
between conditions  
Day 2. 
STAND vs SIT 
˅ glucose iAUC by 19 % 
LW vs SIT 
˅ glucose iAUC by 17 % 
No significant difference 
between conditions  
(Larsen et al., 
2015) 
19 (11 men, 8 women) 
overweight/ obese  
Age: 57 ± 2 y 
BMI: 33 ± 1 kg/m2 
WC: 
Setting: laboratory  
Randomised cross-over  
3 consecutive days per 
condition 
Minimum 12 day 
washout 
Glycaemic outcomes: 
Plasma glycaemia, 
venous blood plasma 
glucose (fasted and 
postprandial) 
1. Sitting 6 h (limit movements 
to activities necessary to 
daily living) 
2. Sitting and 17 light intensity 
walking (3.2 km/h) bouts of 
2 min every 20 min 
Diet: meal tolerance test 75 g 
carbohydrate, 50 g fat,  
LW vs SIT 
˅ glucose iAUC by 32 % 
and 31 % on day 1 and 3 
respectively  
No effect of time, across 
3 days protocol for any 
outcomes  
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Reference Populations Study design/ Outcomes Methods Findings 
(Peddie et al., 
2013) 
70 (10 men, 60 
women) 
Age 25.9 ± 5.3 y 
BMI 23.6 ± 4.0 kg/m2 
WC 76.0 ± 10.7 cm 
Setting: laboratory  
 
Randomised cross-over 
design 
Minimum 6 day washout 
Glycaemic outcomes: 
Venous blood glucose 
(fasted and postprandial) 
1. Sitting 9 h (SIT) 
2. Sitting and walking 30 min 
continuous (CON LW 
3. Sitting and walking bouts of 
1 min 40 s every 30 min 
(INT SIT) 
INT SIT vs SIT 
˅ plasma glucose iAUC 
by 39 %   
CON LW vs SIT 
No significant difference  
INT vs CON LW 
˅ plasma glucose iAUC 
by 37 %   
 
(Pulsford et al., 
2017) 
25 (men) inactive  
Age: 40.2 ±12.2 y 
BMI: 26.1 ± 4.1 kg/m2  
WC: 87.3 ± 9.4 cm  
Setting: laboratory  
Cross-over design 
Minimum 6 day washout  
Glycaemic outcomes: 
Oral glycaemia tolerance 
test, venous blood 
glucose (fasted and 
postprandial) 
Matsuda index 
1. Sitting 
2. Sitting and (?) standing 
bouts of 2 min every 20 min, 
totalling (?) 
3. Sitting and (?) light intensity 
(2 mph) walking bouts of 2 
min every 20 min, totalling 
(?) 
Diet: 75 g glycaemia drink 
(consumed within 2 min) 
LW vs SIT 
˅ glucose AUC by 9 % 
STAND vs SIT 
No significant difference 
for glucose AUC  
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Reference Populations Study design/ Outcomes Methods Findings 
(Thorp et al., 
2014) 
23 (17 men, 6 women) 
Age: 48.2 ± 8.0 y 
BMI: 29.6 ± 4.1 kg/m2 
WC: male: 99.9 ± 10.5 
cm, female: 100.4 ± 
11.3 cm 
Setting: laboratory 
Randomised cross-over 
5 day experimental 
conditions 
Minimum 7 day washout  
Mixed test drink – 
consumed 10 min 
Activity outcomes: 
ActiGraph (run-in phase 
till end of each 
experimental condition) 
activPAL (at all times) 
Glycaemic outcomes: 
Venous plasma 
glycaemia (fasting and 
postprandial – 0, 60, 
120, 180, and 240 min 
post meal)  
1. Sitting 8 h 
2. Sitting 4 h and 4 standing 
bouts for 30 min alternating 
posture every 30 min, 
(totalling 4 h of standing) 
Diet: standardised test drink 
(75 g CHO and 50 g fat), 
standardised meals providing 
70 % EE intake (53-55 % 
CHO, 12-15 % protein, 30-33 
% fat)  
STAND vs SIT 
˅ iAUC glucose by 11.1 
%  
No significant difference 
for fasted glucose 
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2. Free-living studies  
The  majority of research into the glycaemic response to interrupting sitting has taken place in 
laboratory settings (Pulsford et al., 2017; Thorp, 2014;Bailey, 2015;Henson, 2016;Dempsey, 
2016;Larsen, 2015;Crespo, 2016;Hawari, 2016;Dunstan, 2012;Peddie, 2013 ). It can be postulated 
that compliance to protocols for interrupting sitting maybe easier to achieve within a controlled 
laboratory setting compared to free-living conditions (Hillsdon et al., 1995). Within laboratory based 
studies compliance does not appear to be an issue due to the controlled environment as 
participants are closely observed and instructed when to complete their physical activity breaks. It 
is imperative to explore the effects of interrupting prolonged sitting in real-life settings to inform 
public health guidelines based on interventions that are effective and achievable in day-to-day life. 
There has been limited research that examines postprandial glycaemia responses in free-living 
conditions (Duvivier et al., 2016; Duvivier, 2017 ;Duvivier et al., 2013; Brocklebank, 
2017;Altenburg, 2016 ). The details of such studies are outlined in Table 2 and are discussed here 
in more detail. 
 The first study to assess the cumulative effects of interrupting sitting in free-living conditions 
compared three, 4-day activity regimes on glycaemia concentrations in eighteen young healthy 
weight (21 ± 2 y, 22.6 ± 2.6 kg-2) individuals (see Table 1) (Duvivier et al., 2013). The activity 
regimes consisted of: (a) Sitting for 14 h, (b) Exercise: 13 h sitting with 1 h of vigorous exercise, 
and (c) Minimal intensity physical activity: 8 h sitting with 4 h walking and 2 h of standing (Duvivier 
et al., 2013). No significant difference was found between each condition for fasted and 
postprandial AUC for glycaemia after an OGTT (Duvivier et al., 2013). Although novel in its 
methodology, the authors were unable to find a reduction in AUC for glycaemia. However, the 
authors did not measure 24 h glycaemic response over the four condition days. Postprandial 
glycaemic attenuation has previously been observed to not increase in magnitude over a period of 
3 days (Larsen et al., 2015). Therefore, by only measuring glycaemic responses on the final day of 
multiple days of interrupting sitting may miss important postprandial changes that may have 
occurred at an earlier time point. Furthermore, dietary intake was not controlled before the start 
and during each condition. Therefore, glycaemic responses may have been affected by potential 
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differences in dietary intake between conditions. In healthy young adults, no significant difference 
was reported for glycaemia after participants were instructed to remain sedentary for 8 h/day for six 
days (Altenburg et al., 2016). However, participants were unable to significantly increase their 
sedentary behaviour  time during this period (Altenburg et al., 2016). Participants were requested 
to sit for 8 h/day, four of which were required to be uninterrupted, and the remaining four hours 
participants were permitted to interrupt their sitting for a maximum of 15 min/h to allow for activity 
necessary for daily living (Altenburg et al., 2016). When normal habitual days were measured by 
accelerometery, uninterrupted sedentary time was 3.6 h/day. During the increased sedentary days, 
participants were unable to significantly increase their uninterrupted sedentary time. Participants 
were also unable to significantly increase their prolonged sedentary time and glycaemic control 
was unaffected by the experimental period (Altenburg et al., 2016).  
Further exploration of glycaemic response to interrupting sitting in free-living conditions has 
recently been examined in individuals with T2D (Duvivier et al., 2016). Nineteen healthy, 
overweight and obese individuals, diagnosed with T2D completed three, four day experimental 
conditions; Sit: 14 h/day sitting, Exercise: 1 h/day cycling (5 x 20 min, with 5 min rest between) and 
13 h/day sitting, and Sit less: 2 h/day walking, 3 h/day standing, and 9 h/day sitting (Duvivier et al., 
2016). The iAUC for 24 h glycaemiac response  was significantly lower during Sit less compared to 
Sit. Futhermore, 24 h glycaemic resposnes were not significantly different between Sit less and 
Exercise conditions (Duvivier et al., 2016). However, traditional bouts of prolonged exercise, such 
as in those in the Exercise condition may result in hypoglycaemia in indivuals with T2D. The study 
by (Duvivier et al., 2016) postulated that implementing intervetions targeting frequent interruptions 
to may promote attenuated hypoglycaemic fluctuations. However, these findings were observed in 
indivduals with T2D and thus the findings cannot be extrapolated to the wider population, or those 
at an increased risk of developing T2D. Furthermore, Duvivier et al., (2016) investigating the effect 
of replacing SEDENTARY BEHAVIOUR  time as opossed to increasing frequncy of interruptions.  
On such study to investigate the glycaemic response to reducing sitting time on those at an 
increased risk of developing T2D found no significant difference in fasted glycaemia or 
postprandial glycaemic response following an OGTT (Duvivier et al., 2017). Twenty-four sedentary 
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overweight and obese (64 ± 7 y, 29 ± 2 kg/m2) participants competed two, four-day randomised 
conditions; Sit: restrict walking and standing to 1 h/day each, and sit for the remainder of waking 
hours, and Sit less: replace at least 7 h/day of sitting with ≥ 4 h/day of self-perceived light-intensity 
walking and ≥ 3 h/day standing. Participants were also requested to interrupt their sitting every 30 
min (Duvivier et al., 2017). Fasted and postprandial glycaemic samples were only collected and 
analysed after the last day of each condition (day 5) and not during each condition day. Similar 
assumptions to (Duvivier et al., 2013) study can be made regarding potentially missed glycaemic 
responses as the effects of interrupting sitting on glycaemic responses may only be acute (< 1 day) 
in nature. Therefore, investigation into the effect of interrupting sitting on glycaemic responses in 
overweight and obese individuals over multiple interrupting sitting days is required.   
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Table 2. Summary of studies examining glycaemic responses to prolonged sitting and interrupting sitting in free living conditions 
Reference Populations Study design/ Outcomes Methods Findings 
(Altenburg et al., 
2016) 
7 (men) healthy 
Age: 21.4 ± 2.3 y 
BMI: 21.8 ±1.4 kg/m2 
Setting: Two days 
laboratory, with 6 
consecutive free-
living days in the 
middle 
Pilot study – Randomised 
order 
Glycaemic outcomes: 
Postprandial venous 
glycaemia measured 
hourly. C-peptide and 
triglycerides 
 
 
Day - 6 - -1: Habitual activity 
Day 1:  
Sat reclined for 7 h  
Day 2-7: Sedentary days 
Remain seated for at least 8 h 
between 7:00 – 20:00, of which 
4 h uninterrupted  
Day 8: 
As day 1 
Diet: x 2 Standardised high fat 
drink (hour 1, and hour 6) 
Standardised pre-visit meal 
and snack (15 ± 5 g fat, 70  ± 
10 g CHO, 25.8 ± 5.2 g protein, 
526.7 ± 40.4 kcal and 0.6 g fat, 
48.6 g CHO, 2 g protein, 213 
kcal respectively) 
No significant 
difference for glucose 
and triglycerides 
˄ postprandial C-
peptide  
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Reference Populations Study design/ Outcomes Methods Findings 
(Brocklebank et 
al., 2017) 
17 (13 complete data 
sets) 
Age: 54.4 ± 5.1 y 
BMI: 28.0 ± 4.5 kg/m2 
WC: 95.3 ± 10.5 cm 
Setting: participants 
workplace  
Randomised 3-period, 3-
treatment crossover  
24 h washout between 
condition days 
Activity monitoring: 
activPAL and ActivGraph 
(from start of trial 1 until end 
of trial 3)  
Glycaemic outcomes: 
Postprandial interstitial 
glycaemia concentration: 
 
Uninterrupted sitting: 5 h 
uninterrupted sitting 
Stand:  interrupted sitting every 
20 min and stood       still for 2 
min, for 5 h. 
Walk: interrupted sitting every 20 
min with 2 min of self-perceived 
light intensity walking (RPE 9) for 
5 h.  
Diet: x2 200 mL drink (600 kcal, 
73.6 g CHO, 23.6 g protein, 
23.2g fat)  
SIT vs. LW 
˅ 5 h Glucose  
iAUC by 55.5 %  
SIT vs LW vs STAND 
Glucose iAUCt no 
significant difference  
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Reference Populations Study design/ Outcomes Methods Findings 
(Duvivier et al., 
2013) 
18 (2 men,16 women) 
healthy  
Age: 21 ± 2 y 
BMI: 22.6 ± 2.6 kg-2 
Setting: free-living 
conditions 
  
Randomised cross-over 
10 day wash out  
Activity outcomes: 
activPAL (continuously) 
Glycaemic outcomes: 
Oral glycaemia tolerance 
test (75 g glycaemia, 250 
ml water) 
Venous glycaemia 
concentrations (fasting and 
postprandial, 15, 30, 45, 
60, 90, and 120 min), C-
peptide and insulin 
1. Sitting: 14 h/day, 4 days 
2. Sitting and exercise: 13 h, 1 h 
vigorous cycling, 4 days 
3. Sitting and minimal intensity 
physical activity: 8 h, 4 h 
walking, 2 h standing, 4 days 
Diet: 250 ml water and 75 g 
glycaemia 
No significant 
difference for 
baseline or 
postprandial glucose  
Duvivier., et al. 
2016 
19 (14 men, 6 
women) with type 2 
diabetes 
Age 63 ± 9 y 
BMI 30.5 ± 3.3 kg/m2 
Setting:  Free living 
conditions 
Randomised cross-over 
10 day wash out  
Glycaemic outcomes: 
24 h interstitial glycaemia 
concentrations  
Sitting: 14 h sitting/ day, 4 days 
Exercise: 1 h cycling (20 min 
bout, 5 min rest) 13 h sit/day, 4 
days 
Sit less: accumulate 2 h 
walking, 3 h standing (sitting 
interrupted every 30 min) /day. 
4 days  
 
SITLESS vs SITTING 
˅ 24 h glycaemia  
SITLESS vs 
EXERCISE 
No significant 
difference for 24 h 
glucose 
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Reference Populations Study design/ Outcomes Methods Findings 
(Duvivier et al., 
2017a) 
24 (13 men, 11 
women) 
sedentary overweight 
and obese individuals 
Age: 64 ± 7 y 
BMI: 29 ± 2 kg/m2 
Setting: Free living 
conditions  
Randomised cross-over 
10 day wash out  
Activity outcomes: 
activPAL 
Glycaemic outcomes: 
190 min oral glucose 
tolerance test 
Sitting: 13.5 h/day sitting, self-
perceived light-intensity 
walking 0.7 h, standing 1.4 
h/day, 4 days  
Sit less: accumulate 4.3 h/day 
self-perceived light-intensity 
walking, 4 h/day standing 
(sitting interrupted every 30 
min) /day. 4 days  
 
SIT vs SITLESS 
No significant 
difference for 
postprandial and 
fasted AUC 
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3. Research design and methods 
3.1 Participants  
Thirteen overweight or obese, sedentary and inactive adults (n = 5 men, and n = 8 women) aged 
18 – 65 y, with a BMI of ≥ 25 kg/m2 to 45 kg/m2 (Organization, 1995) , and a waist circumference of 
≥ 102 cm for men and ≥ 88 cm for women (Wang et al., 2003) were recruited via advertisement 
and word of mouth at the University of Bedfordshire and in the local community. Participants were 
screened prior to the preliminary visit to determine sedentary behaviour and physical inactivity via 
the International Physical Activity Questionnaire (IPAQ) (see appendix A), and domain specific 
sitting time questionnaire (Marshall et al., 2010) (see appendix B) retrospectively. Exclusion criteria 
were: sitting < 7 h/day, MVPA > 150 min/week, working night shifts, current smokers or smoked 
within the past year, had an artificial pacemaker, known contraindications to physical activity (see 
appendix C), self-reported diagnosis of diabetes, experimental drug use, alcohol abuse, any known 
blood borne disease, pregnancy, and taking glycaemia-lowering and/or lipid-lowering medication 
(see appendix D). Informed consent (see appendix E) obtained from all eligible participants prior to 
testing procedures. Ethical approval was obtained from the University of Bedfordshire Institute for 
Sport and Physical Activity Research Ethics Committee.  
3.2 Sample size calculations 
Previous research reported a 44% reduction in free-living 24 h glucose iAUC in a sit less condition 
compared with a sitting condition (Duvivier et al., 2016). As this study is in non-diabetic 
participants, a conservative 20% variance was assumed as the intervention is expected to have a 
smaller effect. Based on this, it was estimated that a minimum of six participants would be required 
to provide 95% power to detect a significant change in 24 h glucose iAUC with an α of 0.05, a 
within-person correlation of 0.5, and an estimated within-group variance of 20% in this two-
treatment crossover design. 
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3.3 Preliminary testing 
Participants were met by a researcher at their workplace, a communal meeting space, or the 
University of Bedfordshire laboratory for preliminary measures. Participant height was measured to 
the nearest 0.1 cm using a portable stadiometer (Marsden HM-250, Invicta plastics, Rotherham). 
Waist circumference was measured at the midpoint between the lowest rib and the iliac crest to the 
nearest 0.1 cm (Wang et al., 2003). Body mass (kg) and body fat % were measured using the 
Tanita BC-418 Segmental Body Composition Analyzer (Tanita Corp., Tokyo, Japan). This measure 
was used to assess the eligibility of participants in regards to BMI. The bio-impedance analysis 
device uses eight polar electrodes, a single-point load cell weighing system in the scale platform 
and an algorithm to estimate body composition (Völgyi et al., 2008). Bio-impedance is a valid and 
reliable measure for overweight and obese adults (Franssen et al., 2014).  
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3.4 Study design 
A within-subjects randomised crossover study was conducted and comprised of two, 4-day free-
living conditions, separated by a 72 h washout period (see Figure 1). Participants were randomised 
using an online tool that allocated trial order (www.randomizer.org). A washout period of three days 
was included to avoid carryover effects as a single session of exercise may improve insulin 
sensitivity for up to 48 h (Mikines et al., 1988). During the washout period, participants were 
instructed to refrain from engaging in MVPA and from consuming alcohol. Participants were 
instructed to replicate their dietary intake (see meal standardisation) and refrain from taking part in 
any structured exercise during the two, 4-day conditions (Duvuvier et al, 2013; Duvuvier et al., 
2016). Abstinence from alcohol and structured exercise was also required 48 h prior to 
commencement and during both  conditions. Participants were provided with a diary for each day 
of both conditions to record their activity in 60 min blocks from 06:00 – 23:00 hours to encourage 
adherence to the protocols (see appendix F). Within seven days following the preliminary visit 
participants were met at their workplace, a communal space, or the University of Bedfordshire 
laboratory for initial setup of the glucose monitoring device and postural monitor. This setup 
occurred twenty-four hours before study commencement (on a Monday). A FreeStyle Libre (Abbott 
Diabetes Care, Abbott Laboratories Ltd,Berkshire, UK) flash glucose monitor (FGM) was fitted to 
each participant at the midline of the upper arm (see Flash Glucose Monitoring section). 
Subsequently, participants were fitted with an activPAL (PAL Technologies, Glasgow, Scotland) 
activity monitor (see Sedentary Behaviour and Physical Activity Assessment section). Participants 
were instructed to adhere to the following two, 4-day conditions: 1) Sitting, and 2) Interrupted 
Sitting. 
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Figure 1. Schematic of study design FGM; Flash glucose monitoring 
 
3.5 Experimental Conditions 
Following preliminary measures and device set up participants were provided with verbal and 
written protocol instructions. These are outlined in the sections below.   
3.6 Uninterrupted sitting experimental condition 
Similar to previous research, Altenburg et al. (2016), during the Uninterrupted Sitting (SIT) 
condition, participants were instructed to increase their sitting time as much as possible and to 
remain seated for at least 10 h/day during each day of the four condition days (see appendix G). 
Participants were asked to spend 7 of these 10 sedentary hours/day uninterrupted, except for 
visiting the toilet. Participants were not required to remain sedentary for 7 unbroken hours, but 
rather accumulate 7 bouts of a 1 h uninterrupted sitting bout. During the remaining 3 hours, 
participants were permitted to interrupt their sitting time once per hour, up to a maximum of 15 min 
to allow them to carry out activities necessary for daily living, such as cooking and cleaning. 
Participants were instructed to restrict standing and stepping to a maximum of 1.5 h/day during the 
sitting condition. Participants were given an activity log to note each activity per hour. This was 
provided for participants to enable them to visualise their behaviour and to promote condition 
compliance.    
Initial 
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3.7 Interrupted sitting experimental condition 
During the Interrupted Sitting (INT SIT) condition, participants were asked to interrupt their sitting 
time at least once every 30 min with bouts of activity lasting 3 to 5 min during each day of the four 
condition days (see appendix H). Participants were instructed to accumulate a total volume of 6 to 
10 min of interruptions in sitting time per hour, per day (84 to 140 min/day). The frequency and 
duration of interruptions to sitting was selected as current literature has indicated beneficial 
postprandial glycaemic responses (Henson et al., 2016; Dempsey et al., 2016a; Duvivier et al., 
2016; Duvivier et al., 2017). Participants were provided with a list of suggested mobile device, and 
personal computer applications and tools to alert/remind them to interrupt their sitting at least every 
30 min. Participants received suggestions on different activities that they could use to interrupt their 
sitting including walking, standing, stair climbing, and simple resistance activities (e.g. body weight 
half squats, lunges, calf raises, knee lifts, and repeated sit-to-stand transitions).  Interrupting sitting 
with these types of activities has elicited acute beneficial glycaemic responses in laboratory 
conditions (Bailey and Locke, 2015; Dempsey et al., 2016a; Thorp et al., 2014). Participants were 
informed they could select an activity that best suited the situation or environment they were in to 
reduce any potential embarrassment from breaking “cultural norms”. For example; if a participant 
was in a meeting, they could simply rise from a seated position to standing rather than perform 
body weight squats. However, participants were informed that a range of activities were required to 
be performed, and they could not just pick one activity. As above, Participants were given an 
activity log to note each activity per hour. This was provided for participants to enable them to 
visualise their behaviour and to promote condition compliance.    
 
3.8 Meal standardisation 
Participants were provided with two standardised instant pasta meals (464.0 ± 2.0 kcal, 
carbohydrate 80.7 ± 2.8 g, protein 18.2 ± 1.2 g, and 7.0 ± 1.1 g fat) to consume on the evening, at 
the same time, before the start of each four-day condition (see Figure 1). Participants were also 
provided with electronic weighing scales (Salter Disc Electronic Kitchen Scale, HoMedics Group 
Ltd, UK) and asked to weigh and record volume and timings of all food and beverage intake in a 
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food diary during the first 4-day condition and were asked to replicate the exact volume and timings 
of consumption during their second four-day condition.  Participants were provided with a second 
meal log to record replicated food to ensure protocol adherence. The participants were asked to 
consume a minimum of three meals during each experimental condition day that contained at least 
50 % carbohydrate, in addition to any snacks that the participants wished to consume. A list of 
example meals containing a minimum of 50 % carbohydrate was provided to each participant (see 
appendix J). 
3.9 Flash Glucose Monitoring  
A FreeStyle Libre FGM sensor was inserted subcutaneously into the back of the upper arm during 
the preliminary visit. Interstitial glucose monitoring, using the Freestlye Libre, is valid when 
compared to capillary blood glucose reference values using a YSI analyser (Yellow Springs 
Instrument, Yellow Springs, OH) (Bailey et al., 2015). Furthermore, the Freestlye Libre FGM 
provides accurate measurements of interstitial glucose corresponding with capillary plasma 
glucose over 14 days, and is unaffected by participant characteristics (Sekido et al., 2017). An 
interstitial glucose monitoring device positioned on the arm was selected to measure changes in 
glycaemic concentrations rather than the abdomen due to potential deterioration of biometric 
values. Biomechanical factors such as movement and pressure can distorts the tissues physiology 
around the subcutaneously inserted wire sensor and ultimately impact upon sensor performance 
(Charleer et al., 2018). Furthermore, adominal glycaemic concentration have been reported to be 
10 – 18 % lower and report elongated hypoglycaemic eposides compared to than finger capillary 
measures (van der Valk et al., 2002). This may be due to site specific characteristics such as 
excessive subcutaneous fat (van der Valk et al., 2002). Finally, the Freestyle Libre is a factory 
calibrated device which does not require any further calibration from the user, compared to other 
interstitial device which required multiple daily capillary sample calibrations. Thus, this device was 
selected to reduce participant burden and comfort. The accuracy of the factory calibrated flash 
glucose monitoring device has been reported to be similar across the 14 day wear time, apart from 
the first day of wear. It has been reported that the first day of wear has the lowest accuracy. This 
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may be due to the body’s inflammatory response to the sensor being inserted, which has been 
shown to affect glycaemic concentrations in interstitial fluid (Bailey et al., 2015). To attenuate any 
confounding effects, a 24 h run in period was selected. 
Each participant was asked to wear the monitor for a total of 11 full days. An initial 1 h calibration 
was required to set up the monitor. To reduce user error, clear written and verbal instruction were 
provided for the FGM receiver (See Appendix K). Participants were asked to scan the FGM sensor 
at least once every 8 h via the FreeStyle Libre receiver to ensure that the sensor data continues to 
sync with FGM receiver, although they could do this more frequently if desired. An in-built alarm 
system, on the FGM receiver, was set in accordance with each participant’s waking and sleeping 
times, with an alarm every 4 h during waking hours to ensure no data transfer was missed. 
Additionally, participants were advised to scan the sensor when they woke up, at lunch, and when 
they went to bed. 
Glycaemia concentrations were measured in the interstitial fluid of the subcutaneous tissue 
every minute and data averaged for each 15-min period was stored and transmitted to a reader. 
The reader was downloaded by the research team at the end of the last condition day. Interstitial 
glycaemia iAUC, total area under the curve (tAUC) and positive area under the curve (pAUC) 
responses were calculated using the trapezoidal method for day 4 of each condition, to measure 
cumulative glycaemic effects of interrupting sitting. Positive iAUC was calculated as AUC above 
the baseline value only (Brouns et al., 2005).  
3.10 Sitting time and physical activity assessment  
Sitting time and physical activity was monitored during the 11-day period in which each 
participant was involved with the study via an activPAL activity monitor. The monitor was attached 
to the skin on the anterior aspect of the right thigh using a medical grade adhesive dressing. 
Continuous wear was achieved by waterproofing the device with a small flexible sleeve further 
covered by a medical grade adhesive dressing (Hypafix Hypoallergenic Tape,BSN Medical 
Limited, Hull, UK), which allowed participants to shower and bathe. ActivPAL uses algorithms to 
discriminate the commencement and conclusion of each period spent sitting/lying, standing, and 
49 
 
stepping, as well as stepping speed, step counts, and postural transitions by thigh positions 
(Harrington et al., 2011). ActivPAL uses an inbuilt equation: MET· h-1 = (1.4*d) + (4- 1.4) x (c / 120) 
x d (where c = cadence (steps per minute) and d = activity duration (in hours)) to estimate an 
indirect metabolic equivalent (Harrington et al., 2011). Participants were provided with written (see 
appendix L) and verbal instructions on how to affix the activPAL dressing and consumables to 
enable participants to change dressings to clean activPAL placement site or in case of malpractice 
(Edwardson et al., 2016). 
Participants were required to keep a sleep and work log to differentiate between sleep and wake 
time (see Appendix K). Data for postural allocation and energy expenditure was averaged over 
days 1-4 of the Uninterrupted Sitting condition, days 1-4 of the Interrupted Sitting condition, and the 
wash out period. Energy expenditure was quantified as metabolic equivalent of task (MET) by the 
activPAL device to determine sedentary bouts. ActivPAL is a valid measure of METS when 
compared to indirect calorimetry, especially when sedentary and LIPA is performed (Harrington et 
al., 2011).  
3.11 Statistical Analysis  
All statistical analysis was performed using IBM SPSS statistics version 21 (SPSS Inc, Armonk, 
N.Y., USA). Data arepresented as mean (95% confidence interval) unless otherwise specified. 
Quantile quantile plots were used to assess normal distributed of data preceding analysis. 
Statistical significance was set at p ≤ 0.05. The differences in outcome variables between 
conditions was analysed using linear mixed model with activity condition as a fixed factor and 
participants as a random factor with adjustment for potential covariates (FGM analysis: WC, 
baseline glucose values on day 4, and activPAL analysis: activPAL wear-time, and WC) explaining 
residual outcome variances. Dietary carbohydrate consumption, age and sex were considered as 
covariates, but were not used because they were not significantly associated with any of the 
outcome variables (iAUC, tAUC, pAUC). Outcome variables included; time spent sedentary, 
accumulation of sedentary bouts, sit-to-stand transistions, time spent in physical activity (stepping 
and standing) and interstitial glycaemia response (iAUC, tAUC, pAUC) on day 4 of each condition. 
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Cohens’ d effect sizes were calculated to describe the magnitude of differences between 
conditions; 0.2, 0.5 and 0.8 indicated a small, medium or large effect, respectively (Cohen, 1988). 
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4. Results 
 
Forty-seven participants were assessed for eligibility, however 34 participants were excluded prior 
to randomisation (see Figure 2.). After screening, 13 participants were included in the study. The 
anthropometrical, glycaemia, and carbohydrate intake data were reported in Table 3. One 
participant withdrew midway through the study and was excluded from the analysis.  
 
 
 
 
 
 
 
 
 
Figure 2. CONSORT diagram showing participant flow through study (crossover design). 
 
Table 3. Participant characteristics 
Variables Mean ± SD 
N 12 
Men (n) 4 
Age (y) 47.5 ± 9.9 
Height (cm) 167.5 ± 8.5 
Weight (kg) 93.9 ± 13.3 
BMI (kg/m-2) 33.3 ± 5.3 
WC (cm) 107.8 ± 8.9 
BF (%) 39.4 ± 7.9 
Baseline glycaemia (mmol/L) 5.5 ± 0.8 
Data presented as mean ± SD. BMI; body mass index, WC; waist circumference, BF; body fat 
percentage  
 
Assessed for eligibility (n = 47) 
Analysed (n = 12) 
Excluded (n = 34) 
Did not meet eligibility criteria 
(n = 26) 
Withdrew prior to 
randomisation (n = 8) 
Randomised (n = 13) 
Withdrew (n = 1) 
Enrolment 
Allocation 
Follow up 
Analysis 
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4.1 Sitting time and physical activity  
Table 4 shows a significant difference for mean total steps (p =.001, d = 1.18). Furthermore, time 
spent stepping increased significantly by 51.8% (p = < 0.001, d = 1.04).  
Compared to SIT (3265.75 [2210.41, 4321.09]) average total steps increased in INT-SIT 
(5507.27 [4418.36, 6596.17]) on day 4 by 2241.52 steps (p = .001, d = 1.18). Time spent in light-
intensity physical activity for INT SIT (0.67 [0.52, 0.82]) compared to SIT (0.48 [0.34, 0.63]) 
increased significantly by 40.8 % (p = .007, d = 0.73). During INT SIT (1.47 [1.18, 1.76]), total time 
spent in MVPA significantly increased by 57.3 % (p = < 0.001, d = 1.25) compared to SIT. 
Compared to SIT, the number of total sedentary bouts were not significantly different in INT SIT 
(p= 0.872, d = 0.05). SIT conditions (p= 0.872, d = 0.05).  
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Table 4. Sitting time and physical activity during the experimental conditions 
Variables SIT INT SIT P value d 
Sedentary bouts     
Number of sedentary bouts lasting 
0-30 min 
46.68 (38.93, 54.42) 46.57 (38.61, 54.52) 0.980 .01 
Time spent in sedentary bouts 
lasting 0-30 min 
5.09 (3.98, 6.2) 5.79 (4.65, 6.93) 0.238 0.35 
Number of sedentary bouts lasting 
30-60 min 
3.17 (1.56,4.78) 4.85 (3.17, 6.51) 0.118 0.59 
Time spent sedentary for durations 
30-60 min 
2.22 (1.25, 3.18) 2.99 (1.99, 3.99) 0.210 0.44 
Number of sedentary bouts lasting 
60-120 min 
2.09 (1.21, 2.98) 1.42 (0.49, 2.35) 0.269 0.42 
Time spent sedentary for durations 
60-120 min 
2.64 (1.49, 3.79) 1.68 (0.48, 2.88) 0.216 0.46 
Number of sedentary bouts lasting 
>120 min 
.334 (-.02, 0.69) 0.11(-0.26, 0.48) 0.320 0.35 
Time spent sedentary for durations 
>120 min 
.81 (-.84, 1.71) .24 (-0.69, 1.17) 0.329 0.29 
Total number of sedentary bouts  52.27 (45.05, 59.49) 52.96 (45.52, 60.40) 0.872 .05 
Total sedentary bouts (h/day) 10.75 (9.07, 12.44) 10.75 (9.05, 12.46) 0.996 0.28 
Number of sedentary to upright 
transitions 
 
51.94 (44.74, 59.14) 52.76 (45.35, 60.18) 0.845 .09 
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Variables SIT INT SIT P value d 
Physical activity     
Light stepping time (h/day) 0.48 (0.34, 0.63) 0.67 (0.52, 0.82) .007* 0.73 
Moderate to vigorous stepping time 
(h/day) 
0.84 (0.56, 1.12) 1.47 (1.18, 1.76) .000* 1.25 
Total stepping time (h/day) 1.33 (.96, 1.69) 2.14 (1.77, 2.51) .000* 1.04 
Total steps per day 3265.75 (2210.41, 4321.09) 5507.27 (4418.36, 6596.17) .001* 1.18 
Standing time (h/day) 4.32 (3.11, 5.53) 4.39 (3.18, 5.62) 0.864 .03 
Data presented as mean (95 % confidence intervals) p = 0.05 
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4.2 Twenty-four-hour interstitial glycaemic   
Table 5 illustrates that there were no significant differences for 24 h iAUC between SIT and INT-
SIT. Furthermore, there were no significant differences for 24 h pAUC or 24 h tAUC between 
conditions. 
 
Table 5. Mean interstitial glycaemia response on day 4   
Variables SIT INT SIT P value d 
24 h interstitial glycaemia     
iAUC (mmol/L·24 h-1) 4.17 (-2.25,10.87) 7.32(.62,14.01) .472 .27 
pAUC(mmol/L·24 h-1) 147.45 (135.11, 
159.79) 
142.88 (130.54, 
155.22) 
.189 .21 
tAUC (mmol/L·24 h-1) 138.74 (126.69, 
150.78) 
135.57 
(123.54,147.61) 
.683 .15 
Interstitial glycaemia waking h     
iAUC (mmol/L·16 h-1) 5.13 (.05, 10.21) 5.81 (.71, 10.91) .840 .07 
pAUC (mmol/L·16 h-1) 107.851 (98.88, 
116.82) 
103.87 (94.88, 
112.86) 
.201 .25 
tAUC (mmol/L·16 h-1) 101.93 (93.81, 
110.04)) 
98.56 (90.43, 106.69) .272 .23 
Data presented as mean (95 % confidence interval) p = 0.05. iAUC incremental area under the 
curve, pAUC positive area under the curve, tAUC total area under the curve.  
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5. Discussion  
In this randomised cross-over study in inactive overweight and obese adults, no significant 
difference in 24 h glycaemia was found in response to increased steps, LIPA, and MVPA for INT 
SIT condition. These findings address important gaps in the existing literature by examining the 
potential postprandial glycaemic response to interrupting sitting in normoglycemic overweight and 
obese individuals in free-living conditions.  
Although participants accumulated an average of 10.75 h/day total sitting time for SIT condition 
in the current study, this was not accrued in uninterrupted bouts as instructed. The quantity of 
waking hours spent sedentary in durations of 60-120 min and > 120 min indicates that on average, 
3.45 h of uninterrupted sitting lasting at least 60 min was accrued during the SIT condition. This 
was less than half the instructed volume of sitting in that condition (≥ 7 h). Although participants 
reduced their total uninterrupted sitting lasting at least 60 min by 44 % in INT SIT compared to SIT, 
this was not significant, which may indicate that this study lacked power for this variable. One 
explanation for participants not accumulating ≥ 7 h of uninterrupted sitting may include participants’ 
inability to increase their total sitting time during SIT compared to their normal habitual behaviour. 
The inability to increase total sitting time has also been observed in previous free-living studies 
(Altenburg et al., 2016). Participants in the study by Altenburg et al., (2016) were healthy active 
adults and were unable to increase sitting time over a 6 day period. The authors postulated that 
adverse associations between sitting and postprandial glycaemia may only arise when sedentary 
behaviour is sustained for an increased number of consecutive days. Furthermore, without a 
sizable amount of total sitting time, attenuation of postprandial glycaemic response may not occur 
when interrupting sitting time.  
Observational data has suggested that sedentary individuals sit for approximately of 7.48 – 
9.28 h/day sedentary (Matthews et al., 2008). Additionally, in office workers, total sitting time was 
observed to be between 8.46 – 10.15 h/day (Clemes et al., 2014). The total time spent sitting for 
both conditions in this current study is in line with previous findings (Clemes et al., 2014; Matthews 
et al., 2008). As this study was carried out in sedentary office workers in free-living conditions, 
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which included participants’ place of work, the effect of occupational requirements on uninterrupted 
sitting should be determined in future research. A 5 h difference in sitting time between 
uninterrupted sitting and interrupting sitting regimes has previously been reported in response to 
protocols investigated interruptions to sitting time in free-living conditions (Duvivier et al., 2017; 
Duvivier et al., 2016; Duvivier et al., 2013). It can be postulated that individuals who have high 
levels of sitting (≥ 10 h/day) may accrue multiple interruptions to sitting throughout the day 
regardless of total sitting time. Independent of total sitting time, individuals with higher frequency of 
breaks to sitting time are beneficially associated with reduced WC, triglycerides, and 2 h plasma 
glucose compared to those that do not interrupt their sitting frequently (Healy et al., 2008). 
Although no significant reduction in 24 h glycaemic response to interrupting sitting was found in 
this study, it may be postulated that shorter duration sitting time with frequent interruptions to skill 
may still result in health benefits. 
The data from the current study extend the conclusions of Duvivier et al., (2013) who did not find 
a significant effect of interrupting sitting on postprandial glucose in healthy weight normoglycemic 
individuals in free-living conditions. Furthermore, the present study is also in agreement with 
Duvivier et al., (2017) who did not find a significant reduction in fasting or postprandial glucose in 
overweight and obese individuals in response to interrupting sitting with stand and self-perceived 
light-intensity walking in free-living conditions. Participants completed two activity regimes in the 
study by Duvivier et al., (2017) in a randomised cross-over design, which consisted of Sit (standing 
and stepping restricted to 1 h/ day with the rest of the day spent sitting), and Sit Less (7 h/day of 
sitting replaced with 4 h/day of self-perceived light intensity walking and 3 h/day of standing). 
Participants were requested to interrupt sitting with standing and walking in a preferable frequency 
of 30 min (Duvivier et al., 2017). However, participants in the study by Duvivier et al., (2017) 
significantly decreased their sitting time concurrently with an increase in standing and stepping in 
their Sit Less condition compared to the Sit condition. In the current study, participants were unable 
to achieve a reduction in total sitting time.  
Previous research investigating the effects of interrupting sitting in free living conditions in T2D 
have found reductions in 24 h glucose iAUC on day 4 of the interrupting sitting condition compared 
58 
 
to day 4 of the control condition Duvivier, 2016. Participants performed three activity regimes in the 
study by XXX: Sitting (14 h/day sitting with walking, and stepping restricted to 1 h/day), Exercise 
(13 h/day sitting, 1 h/day supervised cycling), and Sit Less (9 h/day sitting, with 2 h/day walking, 
and 3 h/day standing). Participants were requested to interrupt sitting with standing and walking in 
a preferable frequency of 30 min the during Sit Less condition (Duvivier et al., 2016). When 
participants reduced their sitting time by 37 % (from 13.7 h to 8.9 h for Sitting compared to Sit 
Less), this resulted in a significant reduction of 24 h iAUC glycaemic response (Duvivier et al., 
2016). Nevertheless, when sitting time was reduced by 8.7 % from Sit to the Exercise condition no 
significant difference in 24 h iAUC glycaemic response was observed (Duvivier et al., 2016).  
A requirement for participant inclusion in the present study included self-reported sitting for ≥ 7 
h/day. As participants reported high levels of sedentary behaviourduring recruitment, it may be 
postulated that participants were unable to increase their total daily and uninterrupted bouts of 
sitting time significantly during SIT condition, compared to their habitual sitting behaviours 
(Altenburg et al., 2016). However, no habitual accelerometery data was collected prior to study 
commencement. Participants were unable to increase their sedentary time during the SIT condition 
compared to INT SIT. 
 It is important to note that in the current study, participants were not required to meet a 
minimum total time threshold of walking, standing and body weight resistance exercises in INT SIT 
condition. This was to allow participants to select an activity that suited their environment, during 
the interruption to potentially increase adherence to the INT SIT protocol.   Participants were 
instructed to interrupt their sitting every 30 min over a 10 h period in INT SIT condition. Therefore, 
the lack of change in total sitting time between the conditions is not surprising as the intervention 
focused on interrupting sitting not, not reducing total sedentary time. 
During the free-living study by Duvivier et al. (2016) energy intake was standardised for all meals 
and snacks on day 4 and dinner on day 3 of each of their conditions. During this present study, 
participants were instructed to record a food diary for the first four condition days and then replicate 
the exact food intake and timings during the second four condition days. Participants were also 
provided with a pre-packaged pasta meal to consume for dinner the evening before each condition 
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started. Furthermore, throughout the current study participants were instructed to consume at least 
50 % carbohydrates in each meal, therefore participants may not always be able to consume their 
normal diet. A recent study by Duvivier et al., (2017) instructed that participants adhered to their 
normal diet. One explanation for the lack of findings within this study may be due to macronutrient 
compositions of meal consumed. Although instructions were given on the percentage of 
carbohydrates consumed during each meal, no guidance was provided on recommended 
composition of protein, fat, glycaemic index and the portion size of each meal. The co-ingestion of 
fat and carbohydrate during a meal may reduce the postprandial glycaemic response (Collier and 
O'dea, 1983). Obese individuals may often consume foods with a high percentage of fat in greater 
quantities that healthy weight individuals (Westerterp-Plantenga et al., 1996). Therefore, future 
studies investigating postprandial glycaemic response to interrupting sitting, in obese individuals 
should control for macronutrient composition and portion size. In addition to the SIT and INT SIT 
instructions, food diary restrictions may have been too burdensome for participants which may be 
one explanation as to why the experimental protocols not followed.  
It may be that those without existing metabolic impairment, occasionally altering positions for 6 - 
12 min per hour each day in this study, may not represent a sufficient stimulus to alter postprandial 
glucose. Interruptions to sitting may have to involve more frequent and with and at an increased 
volume of physical activity stimulus to be of benefit to the attenuation of glycaemic responses 
(Dempsey et al., 2016b). This may have implications on future study designs examining 
interrupting prolonged sitting in clinical populations. 
 The selected parameters (24 h and waking h iAUC, pAUC, and tAUC) for glycaemic response in 
the current study were chosen due to the continuous wear of the glucose monitoring device. 
However, flash glucose monitoring systems typically receive historic glucose every 15 min, for 8 h. 
This type of system reports glucose trends but not real time glycaemic responses, and capillary 
blood glycaemia may be more accurate in detecting rapidly changing directions of glycaemic 
change, but provides less time points to analyses samples (Bailey et al., 2015). Furthermore, 
capillary and venous glycaemic blood sampling measures can only capture a single reading and 
may miss extreme variability over a certain time frame (e.g. over 30 min) (Bailey et al., 2015). 
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Additionally, this study used flash measurements of interstitial glucose, which have been shown to 
differ in time and magnitude compared to blood glucose samples (Kulcu et al., 2003) Interstitial 
glucose monitoring is a non-invasive method of monitoring glycaemic concentrations. This method 
uses interstitial fluid that surrounds the calls subcutaneously. Glucose travels from blood vessels 
and capillaries, through cell walls into the interstitial space. Samples are obtained via a 
transcutaneous sensor typically inserted into the arm or abdomen, and then sent to a transmitter or 
receiver, (Riddell and Perkins, 2009) During glucose uptake, blood glucose concentrate increases 
quickly, and as glucose is transferred into the interstitial space from blood, interstitial glucose is a 
lower concentration, and lags compared to blood glucose. These differences represent 
physiological variation in glucose uptake and utilisation rather than diminished sensor sensitivity 
(Kulcu et al., 2003). Therefore, sensors may have failed to capture glycaemic responses that had 
rapidly changing velocities and magnitudes. The lack of findings for 24 interstitial glycaemic 
response to interrupting sitting may have been due to measurement method of FGM. Future 
studies should investigate over a longer duration (> 14 days) as this would provide accurate and 
valid glycaemic trends, and patterns in glycaemic response to interrupting sitting.  
It is important to highlight that there were occasions when participants’ 24 h glucose 
measurements fell markedly below their baseline during the SIT condition in the present study. 
Therefore, due to potential postprandial glycaemic variability within this current study, sedentary 
participants may have abnormal glycaemic uptake (Buckley et al., 2013). It is possible that 
interstitial glucose concentration fell below baseline due to baseline glucose being higher in 
individuals with poorer glucose tolerance (Young and Benton, 2014). It has been suggested that 
adults with poorer glucose tolerance may have developed hyperinsulinemia to compensate for 
possible insulin resistance. (Young and Benton, 2014). However, insulin was not measured during 
this study, thus, possible insulin mechanisms cannot be attributed to the data observed. This may 
be the circumstance for participants within in this current study. However, no OGTT was completed 
prior to study to act as a reference point. One possible explanation for no significant difference in 
24 h glycaemia between conditions in the current study may be due to minimal differences in 
physical activity and sitting time observed. Total time spent sedentary was the same between 
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conditions (10.75 h/day). Total steps and time spent stepping significantly increased by 68 and 61 
%, respectively for INT SIT condition compared to SIT, indicating that participants engaged with 
walking as an interruption to sitting. Furthermore, time spent in LIPA and MVPA significantly 
increased by 40 and 75 %. Total mean time spent in sedentary bouts up to 120 min decreased not 
statically, by 70 %. Total mean time spent in sedentary bouts up to 60 min decreased not statically, 
by 36 %. Moreover, shorter interrupted sitting increased, but not significantly by 35 and 14 % for 
mean sedentary bouts lasting 30 min and under 30 min, respectively. It can be suggested that as 
standing time did not increase in INT SIT condition compared to SIT participants did not engage in 
standing as an interrupting sitting method. One explanation for the lack of attenuation in glycaemic 
response for the INT SIT condition compared to SIT may be due to the volume and duration of 
standing accumulated in this present study, as interrupting sitting with standing has previously 
shown to reduce glycaemic iAUC over an 8 h duration in overweight and obese individuals (Thorp 
et al., 2014). In this current study, participants were requested to complete a variety of physical 
activities throughout the day to interrupt their sitting. No minimum quantity thresholds were applied 
to each particular physical activity, only the request that an activity was performed for 3-5 min 
every 30 min. No minimum quantity thresholds were selected regarding the amount of each activity 
used in INT SIT because standing (Thorp et al., 2014), walking at a self-perceived light intensity 
(Duvivier et al., 2013; Brocklebank et al., 2017), walking at a moderate intensity (Dunstan et al., 
2012b; Larsen et al., 2017), and simple resistance exercise (Dempsey et al., 2016a) have all 
shown significant reductions in glycaemic response compared to uninterrupted sitting. As previous 
free-living studies used mixed interrupting sitting methods (i.e. walking and standing), significant 
postprandial glycaemic reductions cannot be attributed to one singular interrupting sitting method 
(Duvivier et al., 2017; Duvivier et al., 2016; Duvivier et al., 2013).  However, in current study 
participants were not able to effectively interrupt sitting compared to SIT. 
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5.1 Strengths and limitations  
The main strength of this current study is that flash glucose monitoring was used to record 
average interstitial glucose every 15 min from the start until the end of experimental procedures in 
addition to an objective measure of sitting, standing and stepping. This resulted in 384 glucose 
observations over a 96 h period. Previous studies have analysed and reported frequency of 
continuous interstitial samples at 5 min intervals using continuous glucose monitors (Brocklebank 
et al., 2017; Duvivier et al., 2017; Duvivier et al., 2016b). However, compared to continuous 
glucose monitoring, flash glucose monitoring using Freestlye Libre does not require user 
calibration, unlike continuous glucose monitors (Bailey et al., 2015). Continuous glucose 
monitoring requires users to perform four fingerpick capillary tests per day (Brocklebank et al., 
2017; Heinemann and Freckmann, 2015). Factory calibrated glucose monitoring devices, which do 
not require finger prick sample calibration may affect glucose stability, particularly postprandially 
(Castle and Ward, 2010). However, factory calibrated devices reduces the burden on participants 
(Bailey et al., 2015). Furthermore, this study included the measurement of 24 h glycaemic 
response over four days and included nocturnal glycaemic responses as sleep may impact total 
AUC glycaemic response to interrupting sitting (Morselli et al., 2010). Another strength of this study 
is that it was conducted in participants’ workplace and home, rather than a laboratory, increasing 
the ecological validity of the findings.  
This study has some limitations. This study was not powered to compare sexes, therefore it was 
not possible to compare sex difference in physical activity between conditions. Anecdotally, women 
informed the research team that compliance was challenging to adhere to over the study duration 
due to household chores and family commitments. However, men reported less challenges with 
adherence to the protocol, as they had more opportunity to be sedentary. It is possible that this 
difference corresponds with duties associated with traditional gender roles. A possible explanation 
for this may be attributed to domestic duties and responsibilities that women have regarding having 
a family (Matthews et al., 2008). Future studies should investigate potential sex differences 
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between men and women’s adherence to uninterrupted sitting and interrupting sitting protocols and 
explore the glycaemic response to such interventions in free-living conditions 
Due to study design, female participants’ menstrual cycle could not be accounted for due to the 
FGM senor only being able to measure interstitial glycaemic responses reliably for 14 consecutive 
days. Therefore, the influence that menstrual cycle may have on glycaemic responses cannot be 
ruled out (Pulido and Salazar, 1999).  
It was unfeasible to blind participants to glycaemic response as synchronisation of receiver and 
interstitial sensor was required every 8 h and the FGM displayed glycaemic readings on the inbuilt 
screen as participants synced their device. This may have influenced the quantity of composition of 
dietary intake over the duration of the first four condition days and could have influence physical 
activity and sedentary behaviour. Participants were instructed to consume the same caloric intake 
for each condition by following a food diary. Although such diaries may be unreliable in absolute 
terms (Duvivier et al., 2013) participants did not alter their diet between conditions as no changes 
in dietary intake were reported during conditions. However, participants may have inaccurately 
reported energy intake or underreported (Goris et al., 2000). However, social bias may lead 
overweight obese individuals to underreporting food intake which has low social desirability to 
confirm to social desirability (Hebert et al., 1995; Lissner, 2002 ). 
Although participants were provided with instructions and demonstrations on how to adhere to 
the study protocols upon recruitment, no other activity feedback was given. This may be a 
limitation of the study. A recent study (Duvivier et al., 2013), investigating glycaemic response to 
interrupting sitting in free-living conditions, provided feedback throughout the conditions to 
participants on how to better adhere to the study protocol by assessing activity data after condition 
day (Duvivier et al., 2013). During screening for (Duvivier et al., 2017) recent study participants 
performed a one day try-out of the Sit Less protocol to ensure that they could achieve the 
requirements of this regime. Although encouragement and contact were made with participants 
throughout the current study to assist with adherence, it was not feasible to meet with participants 
daily or provide physical activity feedback. Additionally, to better explore the ecological benefits of 
interrupting sitting time on postprandial glycaemia, the environment in which research is conducted 
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should be reflective of habitual behaviour (Altenburg et al., 2016). Therefore, future research 
should investigate the effectiveness of interrupting sitting on postprandial glycaemic response 
compare to habitual sitting glycaemic response, rather than larger imposed sedentary bouts as 
individuals may be unable to increase their prolonged and total sitting time. This will provide the 
scientific research discipline with more representative metabolic outcomes compared to 
compulsory sitting time, which may not reflect individual’s characteristic sitting behaviours. As 
participants may have overestimated their prolonged sedentary time during screening for this 
study, pre-enrolment objective assessments of habitual activity may be required to identify suitable 
participants for such studies. Future research should also examine the chronic outcomes from 
interrupting sitting on 24 h glycaemic response in free-living conditions in overweight and obese 
individuals.  
5.2 Conclusion  
To conclude, in overweight and obese participants, it may not be possible to manipulate increases 
or decreases in sedentary behaviour in free-living conditions, therefore, it was not possible to 
compare effects of interrupted sitting versus uninterrupted sitting on glycaemia. However, there 
was an increase in physical activity (steps) in the interrupted sitting condition, but this had no effect 
on glycaemia. Further research to effectively reduce sedentary behaviour in free-living conditions is 
required to inform public health guidelines.  
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Appendices  
 
Appendix A. International physical activity questionnaire  
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
(August 2002) 
 
SHORT LAST 7 DAYS SELF-ADMINISTERED FORMAT 
 
 
FOR USE WITH YOUNG AND MIDDLE-AGED ADULTS (15-69 years) 
 
We are interested in finding out about the kinds of physical activities that people do as part 
of their everyday lives.  The questions will ask you about the time you spent being 
physically active in the last 7 days.  Please answer each question even if you do not 
consider yourself to be an active person.  Please think about the activities you do at work, 
as part of your house and yard work, to get from place to place, and in your spare time for 
recreation, exercise or sport. 
 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous physical 
activities refer to activities that take hard physical effort and make you breathe much harder 
than normal.  Think only about those physical activities that you did for at least 10 minutes 
at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical activities 
like heavy lifting, digging, aerobics, or fast bicycling?  
 
_____ days per week  
 
   No vigorous physical activities  Skip to question 3 
 
 
2. How much time did you usually spend doing vigorous physical activities on one of 
those days? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
Think about all the moderate activities that you did in the last 7 days.  Moderate activities 
refer to activities that take moderate physical effort and make you breathe somewhat harder 
than normal.  Think only about those physical activities that you did for at least 10 minutes 
at a time. 
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3. During the last 7 days, on how many days did you do moderate physical activities 
like carrying light loads, bicycling at a regular pace, or doubles tennis?  Do not 
include walking. 
 
_____ days per week 
 
   No moderate physical activities  Skip to question 5 
 
4. How much time did you usually spend doing moderate physical activities on one of 
those days? 
 
_____ hours per day 
_____ minutes per day 
 
  Don’t know/Not sure  
 
Think about the time you spent walking in the last 7 days.  This includes at work and at 
home, walking to travel from place to place, and any other walking that you have done 
solely for recreation, sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 minutes at a 
time?   
 
_____ days per week 
  
   No walking     Skip to question 7 
 
6. How much time did you usually spend walking on one of those days? 
 
_____ hours per day 
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
The last question is about the time you spent sitting on weekdays during the last 7 days.  
Include time spent at work, at home, while doing course work and during leisure time.  This 
may include time spent sitting at a desk, visiting friends, reading, or sitting or lying down to 
watch television. 
 
7. During the last 7 days, how much time did you spend sitting on a week day? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
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8. If your total engagement in moderate-to-vigorous physical activity is 150 min/week or 
more, has this been a regular weekly occurrence over the past 3 months? 
 
Yes 
 
No 
 
 
9. How often does your job require you to sit for long periods of time during your work-
shift? (please circle one option below) 
 
All  most  some    little of the time  never 
 
 
 
10. On average, how many hours per day do you spend watching TV? (please circle one 
option below) 
 
Less than 1 hour  1-2 hours  2-3 hours  3-4 hours 
 
More than 4 hours 
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Appendix B. Domain-specific sitting time questionnaire 
.  
Domain-specific sitting time questionnaire (Marshall et al 2010) 
Please estimate how many hours you spend SITTING EACH DAY in the following situations: (Please write 
your answer) 
      On a WEEK Day  On a WEEKEND Day 
                  Hours     Minutes   Hours     Minutes 
While travelling to and from places 
While at work 
While watching television 
While using a computer at home 
In your leisure time, NOT including 
Television (e.g., visiting friends, 
Movies, dining out, etc.) 
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Appendix C. Physical Activity Questionnaire example 
 
PAR-Q - Please circle the correct answer. 
 
 
1. Have you ever been told by your doctor that you have a heart condition and advised only to 
participate in physical activity approved by your doctor? 
Yes/No 
 
2. Do you experience any chest pains when you participate in physical activity? 
Yes/No 
 
3. Have you recently experienced any chest pains whilst not participating in physical activity? 
Yes/No 
 
4. Do you ever lose consciousness? 
Yes/No 
 
 
5. Do you ever lose your balance as a result of dizziness? 
Yes/No 
 
6. Do you have any problems with your bones and joints that could cause further problems if you 
participate in physical activity? 
Yes/No 
 
 
7. Are you aware of any reasons as to why you should not participate in physical activity? 
Yes/No 
 
 
 
Name: ................................ Signature: .............................. Date: ..................... 
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Appendix D. Pre-study health questionnaire 
 
Sport and Exercise Science Laboratories 
Polhill Avenue 
Bedford MK41 9EA 
 
PRE-STUDY HEALTH QUESTIONNAIRE 
 
To be completed by all participants before participating in practical sessions. 
Name: ………………………………………………….  
 
Age:……………   Gender:  M    /    F 
 
1 Are you in good health?       Yes    /    No 
If no, please explain:      
 
2 Are you pregnant or have you given birth in the last 6 months?   Yes    /    No 
 
3 How would you  describe  your present level  of  moderate activity? 
 < once per month 
     once per month 
     2-3 times per week 
     4-5  times per week 
  > 5 times per week 
 
4 Have you suffered from a serious illness or accident?    Yes    /    No 
If yes, please give particulars: 
 
5 Are you recovering from an illness or operation?    Yes    /    No 
If yes, please give particulars: 
 
6 Do you suffer, or have you ever suffered from: 
Respiratory conditions (asthma, bronchitis, tuberculosis, other)?    Yes    /    No 
Diabetes?      Yes    /    No 
Epilepsy?      Yes    /    No 
High blood pressure?      Yes    /    No 
Heart conditions or circulation problems: 
(angina, high blood pressure, varicose vein, aneurysm, embolism, heart attack, other)?  
Do you have chest pains at any time?       Yes    /    No 
Do you suffer from fainting/blackouts/dizziness?           Yes    /    No 
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Is there any history of heart disease in your family?     Yes    /    No 
 
7 Are you currently taking medication ?    Yes    /    No 
If yes, please give particulars: 
 
8 Are you currently attending your GP for any condition or have you consulted your doctor in the last three 
months? If yes, please give particulars:   Yes    /    No  
    
 
9 Have you had to consult your doctor, or had hospital treatment within the last six months?  
       Yes   /  No 
 
10  Are you currently fitted with a pacemaker?                                                    Yes   /  No 
 
11   Have you, or are you presently taking part in any other laboratory experiment?   
        Yes    /    No 
 
12   Has your body weight been stable for the past 6 months (i.e. not varied by more than 2 kg/4.4 lb)? 
        Yes    /    No 
 
13   Are you currently dieting?        Yes    /    No 
 
14 Do you have any food allergies?      Yes    /   No 
 If yes, please state what this allergy is…………………………… 
 
 
DECLARATION 
 
My replies to the above questions are correct to the best of my belief and I understand that they will be treated 
with the strictest confidence. The experimenter has explained to my satisfaction the purpose of the experiment 
and possible risks involved. 
 
I understand that I may withdraw from the experiment at any time and that I am under no obligation to give 
reasons for withdrawal or to attend again for experimentation. 
 
Furthermore, if I am a student, I am aware that taking part or not taking part in this experiment, will neither be 
detrimental to, or further my position as a student. 
 
I undertake to obey the laboratory/study regulations and the instructions of the experimenter regarding safety, 
subject only to my right to withdraw declared above. 
 
Name of participant (please print) ________________________________________________ 
81 
 
 
Signature of participant __________________________________             Date: ___________ 
 
Name of Experimenter (please print)____________________________________________ 
 
Signature of Experimenter  _____________________________              Date: __________  
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Appendix E. Participant information sheet and participant consent form example 
 
 
 
INFORMATION SHEET 
Blood sugar responses to interrupting prolonged sitting with short bouts of activity 
Dear Participant, 
 
Thank you for showing an interest in participating in the study. Please read this information sheet 
carefully before deciding whether to participate. 
 
What is the aim of the project? 
The aim of this study is to evaluate the effects of interrupting prolonged sitting with short bouts of 
activity on blood sugar levels that will be measured continuously day and night.  
 
What type of participant is needed? 
We require adults aged 18-55 years who sit for an average of 7 hours or more per day and have a 
higher than average body weight for their height. Participants excluded from this study are 
individuals with any known blood borne disease, pregnancy, diagnosed diabetes, taking glucose-
lowering and/or lipid-lowering medication, has an artificial pacemaker, any known health problems 
that prevent you from taking part in physical activity, or other health issues that may limit the ability 
to perform the necessary activity bouts.  
As it is not feasible to list every medical condition, it is possible that individuals with other medical 
conditions, not given above, may be excluded from the study. 
  
What will participants be asked to do? 
You will be required to attend the University of Bedfordshire Sport and Exercise Science 
Laboratories on two separate occasions. The first visit will last for approximately 2 hours. During this 
visit, you will have your height, weight, and body fat levels measured. You will then be fitted with a 
small sensor which goes into the skin on the back of your arm that will measure your blood sugar 
levels continuously. You will also have an activity monitor stuck to your thigh. You will be asked to 
wear both the blood sugar monitor and activity monitor for 12 to 14 days continuous days. During 
the 11 days, you will be asked to scan the blood sugar monitor attached to your arm 3 times a day 
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using a small device that we will provide to you. You will be shown how to do this and have an 
opportunity to practice doing it with the research team, and provided with written instructions.  
During the 11 days that you are fitted with the blood sugar and activity monitors, you will be 
asked to complete the two conditions described below. The first condition will be undertaken on 
days 1-4 and the second will be undertaken on days 8-11. There will be a 3 day gap between each 
of these conditions where you continue your normal daily routines. You will also be asked to record 
all food and beverages you consume during days 1-4 and replicate this consumption exactly during 
days 8-11.  
IMPORTANT: We will ask you not to take part in any planned exercise throughout the study 
period. 
The conditions are: 
1) Sitting – You will be asked to sit for as much as possible during these 4 days. You will be asked 
to restrict the amount of walking and standing you do.  
2) Interrupted Sitting – You will be asked to regularly interrupt your sitting time using a range of 
simple physical activities between 7am and 9pm on each of the 4 days. We will demonstrate 
some example activities to you. To remind you to interrupt your sitting regularly, we will also ask 
you to download a phone app or computer software to help you with this. 
On the days between these two conditions, you will be asked to continue your normal daily routine, 
but not to engage in any exercise. A member of the research team will also contact you daily to 
check everything is working ok with your blood sugar and activity monitors. 
The final visit to the laboratory will last approximately 30 minutes, where you will return your 
blood sugar and activity monitors.   
 
What are the possible risks of taking part in the study? 
There is a small risk of inflammation or infection at the site of insertion of the blood sugar sensor in 
your arm. This will be minimised by only using sensors that have been kept secure in their sterile 
packaging and ensuring the skin is appropriately cleaned before insertion of the sensor. There is a 
small risk that the medical grade dressing used to attach the activity monitor to the skin could cause 
irritation. Please remove the device and attachment if this occurs and contact the research team to 
discuss an alternative dressing withdrawal from the project. Please contact the research team if you 
have any queries regarding the blood sugar or activity monitors during the study.  
 
What if you decide you want to withdraw from the project? 
If, at any stage you wish to leave the project, then you can. There is no problem should you wish to 
stop taking part and it is entirely up to you. There will be no disadvantage to yourself should you 
wish to withdraw.  
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Will my taking part in the study be kept confidential?  
Yes. We will follow ethical and legal practice in accordance with the Data Protection Act (1998). All 
information and results collected will be held securely at the University of Bedfordshire and will only 
be accessible to senior members of the research team. Access to identifiable data (name, address 
etc.) will be limited to selected members of the research team and will be kept on secure University 
computers. This information and other personal details will not be included in analysis, or in 
publications or reports. All information collected during the study will be identified by a unique code 
so that you cannot be identified from it.  All data will be kept on secure computer servers and in 
locked filing cabinets within a locked office at the University of Bedfordshire. 
 
What will happen to the results of the study? 
Everyone that takes part in the study will receive the results of the study once available. The results 
may be presented at academic conferences and/or published in academic journals.  
 
What if I have any questions? 
Questions are always welcome. Please contact one of the following research team members to ask 
questions: 
 
Miss Charlotte Stringer: Charlotte.Stringer@study.beds.ac.uk, 07752 145017 
 
Dr Daniel Bailey (Academic supervisor): Daniel.Bailey@beds.ac.uk, 01234 793237 
 
Many Thanks,  
Charlotte Stringer, Daniel Bailey 
Institute for Sport and Physical Activity Research 
University of Bedfordshire, 
Bedford Campus, 
Polhill Avenue, 
Bedford 
MK41 9EA 
Participant Consent Form 
UNIVERSITY of BEDFORDSHIRE 
 
Title of study: Blood sugar responses to interrupting prolonged sitting with short bouts of activity 
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I confirm that I understand the nature of the practical test above and what is involved in the protocol 
outlined.  I further confirm that my health is normal and the information given on the health/medical 
questionnaire is accurate and complete. 
My agreement to participate in the experiment is made of my own free will, and not in response to 
financial or other inducements (e.g. peer pressure).  I confirm that I am not currently participating in an 
experimental trial. 
The attention of volunteers is drawn to the fact that in the case of injury to persons or damage to 
property no claim for damages can succeed against University of Bedfordshire or against its employees 
unless legal liability resulting from negligence can be proved. 
 
Name:  __________________________________________________ 
 
Signed: __________________________________________________ 
 
Date:  __________________________________________________ 
 
Email address: __________________________________________________ 
 
Phone number:__________________________________________________ 
 
Researcher:  __________________________________________________ 
 
Signed: __________________________________________________ 
 
Date:  __________________________________________________ 
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Appendix F. Daily activity record sheet example  
Time Condition Activity during the hour 
e.g. asleep, sat, stood 
Duration 
Example 
1 
SIT Sat 1 hour 
Example 
2 
INT SIT  Sat 
Stood  
Sat 
30 mins 
5 mins 
25 mins 
06:00 
 
   
07:00 
 
   
08:00 
 
   
09:00 
 
   
10:00 
 
   
11:00 
 
   
12:00 
 
   
13:00 
 
   
14:00 
 
   
15:00 
 
   
16:00 
 
   
17:00 
 
   
18:00 
 
   
19:00 
 
   
20:00 
 
   
21:00 
 
   
22:00 
 
   
23:00 
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Appendix G. Uninterrupted Sitting Instructions 
What to do during your Sitting condition 
 
Dear Participant, 
During the Sitting condition we want you to sit as much as possible. Please follow these instructions 
from dates [……………….] to [……………….] 
 
1. Remain seated for a minimum of 10 hours a day while you are awake on each of the 4 
days.  
 
2. For 7 of these 10 hours, please sit continuously uninterrupted for the full hour, i.e. do not 
get up and move around for the whole hour – only get up if you need to go to the toilet. 
Apart from toilet breaks, please remain seated for as long as possible.  
 
3. Please limit standing and walking to a maximum of 1.5 hours per day. Where possible 
please use public transport or a car to travel to and from places to limit your activity levels. 
 
Please do not engage in any structured exercise, or consume any alcohol during the whole 
study (including the three washout days) 
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Appendix H. Interrupting Sitting Instructions 
Interrupting Sitting Instructions  
Dear Participant,  
During the Interrupting Sitting condition, you will be asked to break up your sitting every 30 minutes 
for each of the 4 days. This will take place on dates [……………….] to [……………….]  
 
Each day please break up your sitting time with 3 – 5 minutes of light or moderate physical 
activity every 30 minutes for a minimum of 10 hours on each day. For example, you may break up 
your sitting time for 6 hours while at work and 4 hours while at home. This means engaging in a 
minimum of 20 breaks per day.  
If you have a long commute to work, need to sit through a long meeting, or cannot stand within a 
particular hour for a different reason, that is ok as long as you break up your sitting time for at least 
10 hours over the day from when you wake up to when you go to bed.   
Please ensure you engage in a minimum of 1.5 hours of standing or physical activity (e.g. 
from the activities below) on each of the 4 days.  
Here are some suggestions for activities you can do during your breaks:  
• Walking at a slow pace (or quicker if you wish to)  
• Walking on the spot  
• Taking the stairs   
• Standing (you could stand when you are unable to engage in the other activities e.g. during 
meetings)  
• Repeatedly get up and down from your chair (chair squats)  
• Body weight half squats   
• Calf raises   
• Butt squeezes  
• Knee raises  
You will be given a demonstration on how to perform these exercises.  
  
  
Please do not engage in any structured exercise, or consume any alcohol during the whole 
study (including the three washout days) 
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Appendix I. 4 day weighed food diary 
 
4 day weighed food diary 
 
Introduction 
 
We would like you to fill out a weighed food diary of all the food and drink you consume during your 
first 4 condition days. You will need to take the food diary with you so you can record what you eat 
and drink whilst you are not at home. 
 
Please replicate this food and drink intake exactly (amount consumed and timings) during 
your second 4 condition days. 
 
Please return a copy of your food diary to us. 
 
Each diary entry should include (See example sheet): 
 
• Everything you eat and drink, it could be a main meal or small snack (including sweets and 
even water). 
 
• Please include extras like sauces, gravies and dressings that you put on you your food. 
 
• Please give as much information as possible about the amount and type of food or drink you 
are consuming (weight of the food or drink, any brand names e.g. Heinz baked beans).  
 
• If possible, please put any packaging in clear bags provided. Especially if you cannot weigh 
the items (i.e. crisp packet eaten out and about) 
 
• Include the time of day, try to say if the meal or snack is for breakfast, lunch or dinner. 
 
• Please list all of the ingredients in whatever item you eat or drink. e.g. If at lunchtime you 
have a ham sandwich you should list the amounts and type of foods (e.g. 2 slices of honey 
roast ham; 15 grams of iceberg lettuce; two slices of wholemeal bread, SEE EXAMPLE 
DIARY). 
 
• There are sections on the diary to enter the different meals you eat (breakfast, lunch, dinner 
etc), separated by a grey bar. If you need more space to write in each section, just go over 
the grey shaded bar into the next section and start the next meal after the next grey shaded 
area (see example). 
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Weighing your food and drink 
 
If you cannot weigh your food or drink, please provide a description of the amount of food or place 
any packaging in the plastic wallet provided and explain the quantity of the packaged food you have 
eaten – just so you can replicate this during your second condition. 
 
Here is an example of how to weigh a ham sandwich with lettuce (make sure the scales are set to 
weigh in grams): 
• Turn on the scales by pressing the ON button 
 
• Weigh the empty container. Place the container (e.g. plate) you will be eating from, on the 
scales. You should use this plate to weigh the ingredients on. Make sure you write the 
weight of the empty plate. You should repeat this process if you eat out of or off an 
additional container (e.g. if you have a plate of toast and a bowl of cereal) 
 
• Before putting any food on the plate press the  ZERO button, the scales should now have 
the plate on but display no weight (0.00 grams) 
 
• Add to the plate both pieces of bread (remember to list the type (e.g. wholemeal) in the 
‘Food & Drink’ column. Record the weight (in grams) of the bread in the ‘Weight served’ 
column. 
 
• Press zero to reset the scales to 0.00 grams and add any butter or spread to the bread. List 
the type of and brand of spread and record the weight of the butter in the appropriate 
sections. 
 
• Press zero to reset the scales and repeat the process with the lettuce.  
 
• Whenever a new ingredient is added, the scales should be zeroed so that the weight of each 
ingredient can be recorded separately as it is added to the plate. 
 
• Use the weight on packaging to help diary entries if you consume the total contents of the 
packet. 
 
• You should also record what drink you consume e.g. 1 small glass of water, 1 bottle of 
lucozade. Ideally weight the liquid you consume too if you can. 
 
• Any leftovers, not eaten, should be re-weighed and noted in the diary. If there is food 
leftover, re-weigh the container or containers that you have eaten or drunk from (with any 
leftovers on/in) and write this in the ‘weight leftover’ column on the same line as where you 
have written the weight of the empty container. Put a tick next to the foods or drinks that are 
left on/in the container. 
 
 
Today is_____________                      Today’s date is___/___/___                                 Participant number:                
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Food & Drink (Please describe in 
detail) 
Weight served 
(g) 
Weight leftover(g) (tick items 
left) 
Leave 
blank 
(office use only) 
Weight of empty container _________g                      - remember to weigh your empty plate or container-                                                                        __________g 
 
remember 
to include 
 
Drinks 
 
Snacks 
 
Wrappers 
 
Time eaten: 
______ 
 
Type of 
meal: 
(circle) 
 
  B. L. 
 
  D. S. 
 
 
 
    
    
    
    
    
    
    
    
    
    
    
    
Weight of empty container _________g                      - remember to weigh your empty plate or container-                                                                        __________g 
 
remember 
to include 
 
Drinks 
 
Snacks 
 
Wrappers 
 
Time eaten: 
______ 
 
Type of 
meal: 
(circle) 
 
  B. L. 
 
  D. S. 
 
 
 
    
    
    
    
    
    
    
    
    
    
    
    
Weight of empty container _________g                      - remember to weigh your empty plate or container-                                                                        __________g 
 
remember 
to include 
 
Drinks 
 
Snacks 
 
Wrappers 
 
Time eaten: 
______ 
 
Type of 
meal: 
(circle) 
 
  B. L. 
 
  D. S. 
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Appendix J.  
Example of meals and snacks 
Breakfast  
• Toast with butter and jam 
• Bagel with butter  
• Porridge with milk – Flavoured; Golden 
syrup etc. or plain  
• Cheerios with milk 
• Shredded Wheat with milk 
• Cornflakes with milk 
• Granola with milk  
• Toast Waffles – with or without topping; 
syrup, fruit etc. 
• Scotch Pancakes – with or without 
topping; butter, syrup etc. 
• Toaster Pastries e.g. Pop Tarts 
• Granola bars 
• Fruit; e.g. banana  
 
Lunch  
• Pre-made shop brought sandwich, crisps 
and chocolate bar (meal deals) 
• Homemade sandwich, crisps and 
chocolate bar  
• Bagel with butter and cream cheese  
• Jacket Potato with cheese and beans  
• Pasta meal e.g. pre-packed pasta salad, 
pasta bake 
• Microwave packet or risotto, with optional 
extras e.g. tuna, cheese, eggs, ham 
• Sausage roll 
• Samosa 
• Savoury Eggs – scotch eggs 
 
Dinner 
• Sausage and mash with gravy and 
vegetables 
• Spaghetti Bolognese sauce with garlic 
bread 
• Chilli con carne with rice 
• Packaged pizza 
• Curry with rice and naan bread 
• Pasta Bake  
• Lasagne with garlic bread 
• Breaded cod with oven baked chips and 
vegetables 
• Cottage/ Sheppard’s pie and vegetables 
• Cannelloni 
• Oven baked pie (prepackaged or 
homemade) with oven baked chips and 
vegetables 
• Toad in the hole with mash and vegtables 
• Noodle dish  
Drinks and Snacks 
• Fizzy drinks 
•  Water 
• Coffee and/or Tea 
• Fruit  
• Crumpet with topping; butter, syrup, jam, 
chocolate spread 
• Biscuits / cookies  
• Granola bar / cereal bar 
• Chocolate bar 
• Crisps 
• Rice crackers 
• Cake 
• Sweets  
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Appendix K. Flash Glucose Monitoring instructions 
Flash Glucose Monitoring  
Once you have been fitted with your flash glucose monitoring 
sensor, you will be required to connect the receiver to the 
sensor at least 3 times a day, as shown in the picture. 
This is done by holding the reader within 4 cm of the sensor. 
The reader will beep when the reader has been 
successfully synced. If the sync is not successful, the reader will 
not beep and you will need to try again in 15 seconds.  
 
This will need to be done every 8 hours. The recommended times for this are; upon waking, midday/ at 
lunch, and before bed. However, there is no maximum amount of times that you can connect your device to 
the sensor. You are advised to do this at the recommended times and whenever you remember to 
throughout the rest of the day and night.   
 
The reader battery should last for 7 days, and there will be a charging icon visible. To fully charge the 
battery, please charge the reader for at least 3 hours. This can be done over-night.   
 
The sensor is water resistant and can be worn while bathing and showering but MUST NOT be submerged 
longer than 30 minutes in water.  
 
Note: The reader is not water resistant and should NEVER be submerged in water or other liquids.  
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Appendix L. Thigh Monitor Instructions (activPAL) 
 
 
Thigh Monitor Instructions (activPAL) 
  
How do I wear the monitor? 
• The Thigh Monitor is attached directly onto the skin and positioned on the front of the thigh, roughly 
1/2 of the way between hip and knee with the stick man standing up (see picture). 
• Please wear the monitor every day for the 12-14 days you take part in the study. We will remove 
it when you return to see us during your final laboratory visit. 
• Please wear the Thigh Monitor continuously (24 hours/day) 
• The Thigh Monitor can be worn during sleep and is water resistant (so fine to wear in the bath or 
shower) but please do not wear it when swimming or in the sea. 
• The adhesive patch that sticks the Thigh Monitor to your skin may last up to 8 days but to avoid skin 
irritation you may want to change the adhesive patch. 
Note: The Thigh Monitor will emit a green flash every 6 seconds. This is an indication that it is working and 
recording data.  
 
 
 
 
How do I change the adhesive patch? 
• You can watch this video for guidance on how re-attach your Thigh 
Monitor: https://www.youtube.com/watch?v=BuaRHz_BOA4  
• Remove the Thigh Monitor from your thigh and peel the adhesive patch off the Thigh Monitor. The 
monitor is covered in a waterproof sleeve and wrapped in one adhesive patch—please make sure 
that these remain on the monitor when you do this (they make the monitor waterproof). 
• With an alcohol prep wipe provided, thoroughly wipe down the area of your leg where the Thigh 
Monitor was attached. 
• Position the Thigh Monitor in the same spot as previously on your thigh (or on the other thigh if you 
have had a slight irritation), ensuring that the stick man on the front of the Thigh Monitor is standing 
up (head facing upwards).   
• Peel the covering off an adhesive patch (provided in your pack) and place it over the Thigh Monitor. 
Press the patch onto your skin, starting from the middle out towards the edges peel back the top 
layer of the patch and smooth out the air bubbles and wrinkles as much as possible to ensure that 
the Thigh Monitor is firmly secured to your thigh. 
• If you require assistance re-attaching your Thigh Monitor, or if you experience any skin irritation 
whilst wearing it, please call Charlotte Stringer on 07752145017. 
 
What else do I need to do? 
• It is important that you fill in the Daily Log on the following pages every day for the 11 days while 
you are wearing the monitor.  
• This helps us to look specifically at the data from when you were awake.  
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How to fill in the daily activity monitor log 
 
 
• The log is divided into 11 days. Please complete each question for all of the 11 days. 
Please try and be as accurate as possible—record the exact times if you can, or at 
least to the nearest 5 minutes of your estimated times. 
 
• Start by writing the date in the top row. 
 
• Record the time that you woke up and the time that you actually got out of bed. We 
ask for these two times because people sometimes spend time in bed before going 
to sleep or getting up and we are interested in distinguishing between actual sleeping 
time and time in bed before sleep or once awake, for example going to bed and 
watching TV for an hour before going to sleep.  
 
• Please write AM or PM next to your times. 
 
• Record the time that you started and finished work. This allows us to look at the 
data recorded whilst you were at work. 
 
• Record what time you got into bed to go to sleep and the time that you actually 
went to sleep time. (i.e., the estimated time that you fell to sleep not the time that 
you got into bed). This is important as the monitor cannot tell the difference between 
asleep and awake times.  
 
• Please record your sleep time first thing in the morning when you wake up along with 
recording your wake time and time that you got out of bed. 
 
• If you remove either device for longer than 10 minutes during the day please note 
down the time that you removed the device, the time length that the device is 
removed and the reason why you removed the device. This is particularly 
important as we cannot tell from the data if you are you are lying down or whether 
you have removed the device and are just not wearing it (the data looks the same 
when we look at it). 
 
• Being as accurate and thorough as possible when completing this log enables us to 
look at your data more accurately. 
 
• If you have any questions about the log please contact Charlotte Stringer on 
07745215017. 
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Appendix L. activPAL monitor log
ID Number:  
 
Day and 
date 
Wake up Got out 
of bed 
Started 
work 
Finished 
work 
Got into 
bed 
Went to 
sleep 
Times during the day when I 
took my leg monitor off and 
why 
 
Any other comments 
Example: 
Mon 17th 
Dec 
    
0700am 
0715am 0900am 1700pm  2300pm 2330pm 1600pm for 45 minutes to go 
swimming 
 
Date: 
  
     
 
  
 
 
 
Date:  
 
 
        
Date:         
 
 
 
Date:         
 
 
 
Date: 
(washout) 
       
 
 
 
Date: 
(washout) 
       
 
 
 
Date:         
97 
 
(washout)   
 
Date:         
 
 
 
Date:         
 
 
 
Date:         
 
 
 
Date:         
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